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Statistical Learning and Beherens-Fisher Distribution Methods
for
Heteroscedastic Data in Microarray Analysis
Nabin K. Manandhar Shrestha
ABSTRACT
The aim of the present study is to identify the differentially expressed genes be-
tween two different conditions and apply it in predicting the class of new samples using
the microarray data. Microarray data analysis poses many challenges to the statis-
ticians because of its high dimensionality and small sample size, dubbed as ”small n
large p problem”. Microarray data has been extensively studied by many statisticians
and geneticists. Generally, it is said to follow a normal distribution with equal vari-
ances in two conditions, but it is not true in general. Since the number of replications
is very small, the sample estimates of variances are not appropriate for the testing.
Therefore, we have to consider the Bayesian approach to approximate the variances
in two conditions. Because the number of genes to be tested is usually large and
the test is to be repeated thousands of times, there is a multiplicity problem. To
remove the defect arising from multiple comparison, we use the False Discovery Rate
(FDR) correction. Applying the hypothesis test repeatedly gene by gene for several
thousands of genes, there is a great chance of selecting false genes as differentially
expressed, even though the significance level is set very small. For the test to be
reliable, the probability of selecting true positive should be high. To control the false
positive rate, we have applied the FDR correction, in which the p -values for each of
the gene is compared with its corresponding threshold. A gene is, then, said to be
differentially expressed if the p-value is less than the threshold.
We have developed a new method of selecting informative genes based on the
Bayesian Version of Behrens-Fisher distribution which assumes the unequal variances
in two conditions. Since the assumption of equal variances fail in most of the sit-
vii
uation and the equal variance is a special case of unequal variance, we have tried
to solve the problem of finding differentially expressed genes in the unequal variance
cases. We have found that the developed method selects the actual expressed genes
in the simulated data and compared this method with the recent methods such as
Fox and Dimmic’s t-test method, Tusher and Tibshirani’s SAM method among others.
The next step of this research is to check whether the genes selected by the pro-
posed Behrens -Fisher method is useful for the classification of samples. Using the
genes selected by the proposed method that combines the Behrens Fisher gene se-
lection method with some other statistical learning methods, we have found better
classification result. The reason behind it is the capability of selecting the genes based
on the knowledge of prior and data. In the case of microarray data due to the small
sample size and the large number of variables, the variances obtained by the sample
is not reliable in the sense that it is not positive definite and not invertible. So, we
have derived the Bayesian version of the Behrens Fisher distribution to remove that
insufficiency. The efficiency of this established method has been demonstrated by ap-
plying them in three real microarray data and calculating the misclassification error
rates on the corresponding test sets. Moreover, we have compared our result with
some of the other popular methods, such as Nearest Shrunken Centroid and Support
Vector Machines method, found in the literature.
We have studied the classification performance of different classifiers before and
after taking the correlation between the genes. The classification performance of the
classifier has been significantly improved once the correlation was accounted. The
classification performance of different classifiers have been measured by the misclas-
sification rates and the confusion matrix.
The another problem in the multiple testing of large number of hypothesis is the
correlation among the test statistics. we have taken the correlation between the test
statistics into account. If there were no correlation, then it will not affect the shape
viii
of the normalized histogram of the test statistics. As shown by Efron, the degree
of the correlation among the test statistics either widens or shrinks the tail of the
histogram of the test statistics. Thus the usual rejection region as obtained by the
significance level is not sufficient. The rejection region should be redefined accordingly
and depends on the degree of correlation. The effect of the correlation in selecting
the appropriate rejection region have also been studied.
ix
Chapter 1
Microarrays and Selection of Differentially Expressed Genes
1.1 Introduction
Deoxyribonucleic Acid (DNA) microarray technology was first mentioned in an article
by Schena et. al. [38] published in the ’Genome Issue’ of Science in 1995 . After its
publication, this technology attracted the attention of genome researchers. Nowa-
days, it is one of the most advanced technologies to know the gene expression. In the
course of understanding and deciphering the genomes of many organisms, there was
a need for functional studies of thousands of genes across tissue samples. There was
need for identification of expression patterns of genes under normal and pathological
conditions. The access of genome sequencing was due to the development of high
throughput DNA sequencing technology which created the system to approach biol-
ogy. The most important throughput technology is the DNA microarrays technology
which allows the researchers to make snapshots of genes in an organism in a single ex-
periment. This technology allows the researchers to identify genes that are expressed
in different cell types and conditions, to learn how their expression level changes in
different developmental stages or disease states; and to identify the cellular process in
which they participate. This technology produces a huge amount of information that
can provide clues about how genes and gene product interacts and their interaction
networks. But, transforming this data into knowledge is not a trivial task. Analysis
using multiple techniques is needed to provide the comprehensive view of the under-
lying biology.
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In 1953, James Watson and Francis Crick [50] established the structure of DNA.
The structure of DNA is a double helix, which is like a twisted ladder. Genes are
made up of DNA and RNA (Ribonucleic Acid). Both DNA and RNA are polymers,
that is, molecules that are constructed by sequentially binding the members of a
small subunits called nucleotides into a linear strand or sequence. Each nucleotide
consists of a base, attached to a sugar, which is attached to a phosphate group. The
linear strand consists of alternate sugars and phosphates, with the bases protruding
from the sugars. In DNA, the sugar is deoxyribose and the bases are Cytosine(C),
Guanine (G), Thymine(T), Adenine(A). In RNA, the sugar is ribose and the bases
are Cytosine(C), Guanine (G), Uracil(U) and Adenine(A). The genetic information of
cellular organism is stored in long sequence of these four different bases that bond in
a certain way - A bonds with T (or U), and C bonds with G via the hydrogen bonds.
The sugar-phosphate backbone can, for the purpose of informatics, be considered as
straight; though actually it has all sorts of twists, kinks and loops. The bases that
protrude from the backbone are far more informative. The DNA is, thus, can be
regarded as double stranded polymer. These DNA strands are complementary to
each other meaning that every guanine (G) in one strand corresponds to a cytosine
(C) in other complementary strand, and every adenine (A) in one strand corresponds
to thymine (T) in the other complementary strand. The strings of nucleotides (bases)
are the DNA molecules that compose the genome of an organism. These genome
contain segments of DNA that encode genes. Genes are the functional and physical
units of heredity that are passed from parent to offspring. Genes can be thought as
a segment of DNA sequence that corresponds to a particular protein. Genome is the
set of DNA molecules. DNA has two strands:
1. Sense strand
2. Anti-sense strand
Genes are transcribed into RNA called messenger RNA (mRNA) and are translated
to form proteins. The RNA in the intermediate stage is called mRNA because it is
used as a platform to form proteins from DNA and to pass the information to proteins
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that is encoded by gene or DNA. These proteins are building blocks and functional
units of a living cell. The process converting gene into proteins is called the gene
expression. It occurs in two steps.
1. Transcription : The process of converting DNA into the mRNA
2. Translation : The process of converting mRNA into protein.
The information transfer from DNA to mRNA and mRNA to protein is called the
”Central Dogma of Biology.”
1.2 Gene Expression and Main Question of Interest
Each of the genes encoded in the DNA molecule either transforms into proteins
through the transcription and translation or remains unchanged under that condi-
tion. If the gene is transformed, then we say the gene is expressed in that condition.
DNA is a stable molecule and the same genomic DNA is present, with a few exception,
in all cells of living organism. Despite this all the cells are not the same, like-hair,
muscle, skin cell etc. Why? The difference between the cells is due to the different
subset of genes that are expressed in each of the different cell types. Different subset
of genes are expressed in response to stimuli so that the pattern of gene expression
level reflects both- type of cell and its condition. The amount of each mRNA detected
in the cell can provide information on the corresponding protein and the relationship
between abundance of mRNA and formation of protein.
1.3 What is microarray and how does it work ?
A microarray is typically a glass/ polymer slide onto which DNA molecules are at-
tached at fixed locations, called spots or features. There may be tens of thousands of
spots on an array- each spot containing tens of millions of identical DNA molecules.
For gene expression, each of these DNA molecules should identify (transcribe) to a
single mRNA molecule in a genome. The features are either printed on the microar-
rays by a robot or a jet; or synthesized in situ by photolithography, or by ink-jet
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printing. The most popular microarray application is to compare the expression lev-
els of genes in two different samples; e.g. the same cells under two different conditions.
This is done by labeling the mRNA obtained by the reverse transcription method,
extracted from each sample of two different ways by two colors-green from the normal
and red from the experimental condition. The hybridized microarrays is excited by
a laser and scanned at wavelengths suitable for the detection of red and green dye
intensities.The amount of florescence emitted upon laser excitation corresponds to the
amount of nucleic acid bound to each spot. If the nucleic acid from sample condition
1 is abundance, the spot appears green, while if from condition 2 is abundance, it ap-
pears red; if both are equal, it appears yellow; and if neither present, appears black.
Thus from the florescence intensities and colors of each spot, the relative expression
levels of the genes in both samples are estimated. Hence, thousands of data points
and information of expression levels of a particular transcript can be obtained from a
single experiment. Two types of microarrays are currently available.
1. cDNA microarray
2. Oligonucleotide microarray
1.4 Oligonucleotide microarray
These are the list of terms that are used in this type of microarrays. Probe: oligo-
nucleotides of 25 base pair length used to probe RNA targets. Perfect Match:
probes intended to match perfectly the target sequence. PM: intensity value read
from the perfect matches. Mismatch: the probes having one base mismatch with the
target sequence intended to account for non-specific binding. MM: intensity value
read from the mis-matches. Probe Pair: a unit composed of a perfect match and
its mismatch.
Oligonucleotide arrays are used to measure the abundance of mRNA transcripts
for many genes simultaneously. 11 to 20 perfect match (PM) and mismatch (MM)
probe pairs are used to measure the expression level of each gene. Here is an example
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of probe and PM and MM: Probe Pair: This consists of the 4 kinds of bases: A,C,
G, T. Generally, 25 of these base sequence is selected from the gene of interest.
5”...........A GGG T G CCCCTTTG AAA......3” (sense strand)
3”...........T CCC A C GGGGAAAC TTT.....5” (antisense strand)
to
5”...........A GGG U G CCCCUUUG AAA......3”
3”...........U CCC A C GGGGAAAC UUU......5”
translation into mRNA
The only difference between DNA and RNA is that the base thymine (T) is replaced
by the base uracil (U).
Examples of PM and MM probes:
PM probe: ATGATCTCGAATAGCGTGCGCGAAT
MM probe: ATGATCTCGAATTGCGTGCGCGAAT
This is an example of probe pair. 11-20 such probe pairs of 25-bases is chosen in
each spot of microarray to get the expression of a gene. The polymer such formed
is also called a probe for a gene. The two probes are called complementary to each
other. The only difference between PM probe and MM probe is that the middle base
(A in the above example) is flipped to its complementary base T. Then simple or
weighted/robust average of the difference PM-MM of all probe sets is taken. This is
called the average difference which measures the abundance of mRNA in the oligonu-
cleotide affymetrix data. The human genome has about 2.8 × 109 base pairs and it
encodes at least 40, 000 genes.
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1.5 cDNA Microarray
The mRNA from two tissues are extracted, separately reverse transcribed, and la-
beled with different colors- green (Cy3), red (Cy5). The mixture labeled cDNA are
hybridized onto the different spots of glass slides (called microarray). These spots
already contains the abundance identical probe sequence of complementary DNAs.
Thus the colored cDNAs compete to bind (hybridize) to their complementary cDNA
in each spot. After hybridization, the microarray slide is washed and they are scanned
at different wavelengths by a laser or by a charged-coupled device (CCD) camera to
obtain numerical intensity of each dye. Since the values thus obtained are so large,
the statistical analysis are done transforming into log(cy5/cy3). Generally base 2
is taken because, it equivalently transforms up-regulated and down-regulated genes.
The intensities ranges from 0 to 216.
The advantage of cDNA microarray is that they can be prepared directly from
the isolated clones. Once the set of corresponding PCR products has been gener-
ated, microarrays can be created in multiple versions containing the entire set of
cDNA sequences, resulting in the large-scale arrays for identification of differentially
expressed genes of nterest.It is less expensive to prepare. The cross-hybridization be-
tween homologous sequence is problematic for cDNA microarrays. The advantage of
oligonucleotide microarrays is that they can be synthesized either in plates or directly
on solid surfaces; making it easier to prepare. They are expensive and the probes
in such array can be designed to represent unique gene gene sequences so that the
cross hybridization between related gene sequences is minimized to a degree depen-
dent upon the completeness of available sequence information.
Microarrays are applied to different situations. It helps to find the genes that are
differentially expressed in different conditions. So, it has enormous importance in the
field of Bio-medicine and Genomic. For example, as mentioned in the paper of Efron
et al. [12], some cancer patients have severe life- threatening reactions to radiation
treatment. So, it is important to recognize the basis of this sensitivity, so that such
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patients can be identified before treatment is given. The treatment is life threatening,
so if given to such patients who are sensitive to radiation it can threaten life and
hence decision should be taken before use.
1.6 Measuring the Expression Levels of a Gene
The starting point of any statistical analysis begins from the estimation of expression
level of each gene in the microarray. To measure the real gene expression, we have to
measure the abundance of proteins. However, DNA microarray experiments measure
the abundance of mRNA, but not the protein abundance. According to the simple
traditional view of gene expression, there is a direct one-to-one mapping from DNA
to mRNA to protein. To put in another way, a specific gene (i.e. genomic DNA
sequence) always produce one and the same amino acid sequence of corresponding
protein, which then fold to assume its native state. Given this simplified scheme,
measuring the mRNA abundance would provide us with highly accurate information
on protein abundance, as protein and mRNA abundance are proportional to direct
mapping. There are thousands of spots (features) in a microarray slide. Each spot
is associated with just one gene. For each gene/spot/feature, the amount of mRNA
present is measured by the principle:
Amount of florescence emitted ∝ αm, where, m is the amount of mRNA present
in the spot.
To measure the expression level, the hybridized microarray is excited by the laser and
scanned at the wavelengths suitable for the detection of both red and green inten-
sities. From the florescence intensities and color of each spot/gene, we measure the
expression level of the gene in the spot. Suppose that for gene g,
Rg = expression level ( florescent intensity) of gene g in query sample
Gg = expression level(florescent intensity) of gene g in reference sample, and
Tg =
Rg
Gg
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is the ratio of intensities between query and reference sample.
• If the spot appears red, then T > 1.
• If the spot looks yellow, then T = 1.
• If the spot appears green , then T < 1.
• If the spot appears black, T is undefined.
Similarly, for the two sample with replication, we measure the expression levels
of green and red intensities of the same gene at more than one spot and we get the
values of expression for two different condition.
The quality filtering is implemented to produce good quality of intensity measure-
ment. For this, one uses the multiple spot replication slides. Multiple spotting of
target DNA on a slide provides a means to assess the quality of data for a gene on
that slide. Suppose each gene is spotted p times on the slide. For each spot, a ratio
of Cy3 and Cy5 intensity is calculated as m = Cy3/Cy5. Let CV = σ/m¯ be the
coefficient of variation of the set of ratios m1,m2, ...,mp on the multiple spots. The
quality of the data on the expression level of each gene is inversely related to its CV.
For each gene, a window subset containing 50 genes whose mean intensities are closest
to the gene of interest is constructed. The CV of each gene is calculated and ordered
in the increasing order. If the CV of the gene of interest falls within the top 10% of
the CV’s then we discard this gene saying it has poor quality.
1.7 Statistical Methods for Differentially Expressed Genes
An exciting development in genomic is the use of microarray technology to simulta-
neously monitor the expression levels of thousands of genes. A common task is to
compare the expression levels of genes in samples drawn from two different condi-
tions. Specially, it is of interest to detect genes with differential expression under
two different conditions. In early days, the simple method of fold-change was used
and now it is known to be unreliable (Chen et al. [7]) because statistical variability
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was not taken into account. Since then many more sophisticated statistical meth-
ods have been proposed ( e.g. Chen et al.[7]; Efron et al. [12]; Newton et al.[29];
Tusher et al.[48]; Pan et al. [30]). It has also been noted that the data based on
a single array may not be reliable and may contain high noises. As the technology
advances, microarray experiments are becoming less expensive , which makes the use
of multiple arrays (or multiple spots on each array) feasible. Hence it is possible to
use the test that requires replicated measurements of expression levels of each gene
under two different conditions. A straight forward method is to use the traditional
two sample t-test. Thomas et al. [46] proposed a regression modeling approach. Pan
et al. ([30]) suggested the a mixture model approach, which follows the basic idea of
Efron et al. [12]and Tusher et al. [48]. On the other hand there are different methods
using Bayesian and empirical Bayes method. Other methods are the linear models
and empirical Bayes method of Smyth (2003 )and ANOVA approach of Kerr et al.[22].
The other efficient methods are given by Florence et al. 2007 based on the Johnson’s
distribution.
1.8 Methods for cDNA Data
A number of methods have been suggested for the identification of differentially ex-
pressed genes in single-slide two-color microarray experiments. In such experiments,
the data for each gene consist of two fluorescence intensity measurements. Let R
and G be the expression level of the gene in the red (Cy5) and green (Cy3) la-
beled mRNA samples respectively. Generally, the data consists of the value of the
logarithmic base two of R/G. The advantage of this transformation is that it pro-
duces a continuous spectrum of values for differentially expressed genes while treat-
ing up-and down-regulated genes equivalently. For example, if the expression ratio
R/G = 4, 2, 1, 1/2, 1/4, the logarithmic base 2 has values 2, 1, 0,−1,−2. So, if the
data is transformed by logarithmic base 2, then an up-regulated gene by 4 has value
2, and down-regulated gene by 4 (ratio = 1/4) has value −2.
Early analysis of microarray data (Schena et al., [38]) relied on the fold change
cut-offs to identify differentially expressed genes. Typically a fold change equal to
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2 or 3 is taken as the cut-off. If a gene has logarithmic base 2 ratio greater than 2
then the gene is said to have differentially expressed. Schena et al.[38] used a spiked
control in mRNA samples to normalize the signals for the two fluorescent dyes and
declared a gene as differentially expressed if the difference of the expression levels is
more than 5 in two mRNA samples.
Let mg = log2
Rg
Gg
be the log expression of gene g. If m′g = log2
R′g
G′g
be the log
ratio of N ”housekeeping genes”, that is the genes believed not to be differentially
expressed between two conditions of interest. Let m′ be the mean and s′ be the
standard deviation of these house keeping genes. De Risi et al.( 1996)[8] declared the
genes as DE if
|mg −m
′
s′
| > 3 (1.8.1)
A slightly more sophisticated approach involves calculating the mean and the
standard deviation of the distribution of the ratio mg and defining the global fold
change difference and confidence. The ratio-intensity plot reveals that the data has
more variability at lower intensities and less variability at higher intensities. So,
using a sliding window at each gene we can access the local structure of the data to
determine its differentiability. Let x¯g and sg be the mean and standard deviation of
log-2 ratio of gene g calculated by taking all the genes within the window, then
zg =
x¯g
sg
(1.8.2)
is normally distributed with mean zero and standard deviation 1. Declare the genes
as differentially expressed if |zg| > 1.96. At higher intensities, sg will be bigger and
allows changes to be identified where the data is more variable.
Kerr et al. [22] introduced the use of ANOVA models that accounted for ar-
ray, dye, and treatment effects for cDNA arrays. In this fashion, normalization was
accomplished intrinsically without preliminary data manipulation. The model they
proposed can be written as
yijk = µ+ Ai + Tj +Dk +Gg + AGig + TGjg + ²ijkg (1.8.3)
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where, µ is the mean expression, Ai is the effect of the ith array, Tj is the effect of
the jth treatment, Dk is the effect of the kth dye, Gg is the effect of the gth gene,
and AGig and TGjg are the interaction effects. Of interest for testing the differential
expression are the interaction effects, TGjg, for which appropriate contrast can be
estimated for each gene. in this model all effects were considered as fixed effects and
other terms could be incorporated in the model.
1.9 Methods for Oligonucleotide Data
To detect the DE genes between two different conditions, the two sample t-test and
its variants have been frequently used. Specifically, if we have samples from two
conditions, the t-statistic is given by
t =
x¯2 − x¯1
s
√
1
n1
+ 1
n2
(1.9.4)
where, x¯ are the means and s is the pooled sample standard deviation.
It is hard to verify the underlying assumption of normality because of small sample
sizes perfectly, but with the common technologies this assumption is reasonable for
the logarithm of the expression levels [1], [13], [11]. Baldi and Long [1] proposed a
Bayesian version t-statistic using the priors. More specifically, if the xc1, x
c
2, ..., x
c
nc and
yt1, y
t
2, ..., y
t
nt be the log transformed expression levels in the control and treatment
conditions respectively, they have assumed the data has been transformed into the
form such that normality assumption holds. So x ∼ N(µ, σ2). The priors for means
and variance has been chosen as
p(µ|σ2) = N(x;µ0, σ
2
0
λ0
) p(σ2) = IG(x; ν0, σ
2
0) (1.9.5)
where, IG is the scaled inverse gamma pdf with degree of freedom ν0 > 0 and scale
σ0 > 0
IG(x; ν0, σ
2
0) =
(ν0/2)
ν0/2
Γ(ν0/2)
σν00 x
−(ν0/2+1)exp(−ν0σ
2
0
2x
)
11
The prior is obtained as
p(µ, σ2) = p(µ|σ2)p(σ2).
With this prior, the posterior was of the same form as prior, hence it was the conjugate
prior. Taking µ0 = x¯ and using the mean of the posterior distribution, the maximum
a posteriori (MAP) estimate for mean µ and variance σ2 was shown to be
µˆ = x¯ σˆ2 =
ν0σ
2
0 + (n− 1)s2
ν0 + n− 2 (1.9.6)
Other researchers used the log-normal and gamma-gamma model to detect the DE
genes ( Newton et al., [29]). Since the small variance gives rise to large t-statistic,
empirical Bayes (EB) method of analyzing microarray data was used by Efron et
al.[12] without assuming any distributional assumption of the data. They slightly
tuned the t-statistic by adding a suitable constant, a0, which is generally taken as
90th percentile of standard deviation, on the Z-score obtained like in t-test,
Z =
D¯i
a0 + Si
where, Si is the standard deviation of the ith gene. If p1 (p0) are the prior probability
that the gene is expressed (not expressed), p1(z) (p0(z) are the posterior probabilities
of a gene is expressed (not expressed), f1(z) (f0(z)) be the density of the expressed
genes, then the mixture density for a gene is given by
f(z) = p0f0(z) + p1f1(z). (1.9.7)
The densities f0(z) and f1(z) were estimated from the data without assuming any dis-
tribution, so it was called the Empirical Bayes approach. The posterior probabilities
can be written as
p1(z) = 1− p0f0(z)
f1(z)
, p0(z) = p0
f0(z)
f1(z)
(1.9.8)
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The ratio f0(Z)
f1(z)
was obtained by fitting the logistic regression model
logit(p1(z)) = β0 + β1z (1.9.9)
and the priors p0 and p1 were estimated by
p1 ≥ 1−min
z
f(z)
f0(z)
, p0 ≤ min
z
f(z)
f0(z)
(1.9.10)
The estimate of the sample variance is not reliable for small sample data, specially
in the case of microarray data, Tusher et al. (2001) [48] proposed the statistical
analysis of microarray (SAM) method to stabilize the effect of large variances arising
from low expressed genes. In this method, the SAM statistic is the same as in (1.9.4)
but a small fudge factor s0 is added in the denominator. The value of the fudge factor
is chosen so that the coefficient of variation of the t-statistics is constant as a function
of standard deviations. Generally, 90th percentile of si is used as the fudge factor.
After estimating the fudge factor, the t-scores is ranked in the decreasing order of
t-statistics, i.e. t(1) ≥ t(2) ≥ ...... ≥ t(p), where, p is the number of genes. To select
the threshold ∆ to determine the genes with t-scores greater and/or smaller than the
threshold are differentially expressed, SAM uses the permutation of columns(arrays).
The first n1 of the permuted columns are taken to be as from condition 1 and the
remaining columns are taken to be as from condition 2. We permute the arrays, say-
B times. In each permutation b = 1, 2, ....B, the t -score thus obtained is ranked, say
tb(1) ≥ tb(2) ≥ ...... ≥ tb(p). The expected order statistics of gene g is calculated
by tE(g) =
1
B
∑B
b=1 tb(g). This means that look the gth descending ordered row
g = 1, 2, .., p of each column and take the average. This gives the expected order of
gth ordered gene t(g) in the original ordering. The false discovery rate is calculated
by
ˆFDR =
1
B
∑B
b=1Nb
N
where, Nb is the number of genes in the bth permutation that has expected score
smaller or greater than lower cut point, t(g0), and upper cut point, t(g∗), respec-
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tively, and N is the number of genes that has original t-score smaller or greater than
t(g0) and t(g∗) respectively.
1.10 Assessing the Reliability of Tests
The p-value was invented for testing the single hypothesis. But, in microarray data,
there are thousands of genes, so, we need to test thousands of hypothesis simulta-
neously. In the case of repeated testing of hypotheses, the p-value is conceptually
associated with the specificity of the test, i.e. it is used to control the false pos-
itive rate of a test. Declaring a test to be significant when p-value < 0.05 means
that we are setting specificity 0.95. False discovery rate (FDR) of a test is defined
as the expected proportion of false positives among the declared positives/significant
results. If we declare 100 genes are significant and FDR is 0.1, then this means that
we expect maximum of 10 out of 100 genes are false positives. No such interpretation
is available from the p-value. The false negative rate (FNR) is defined as the expected
proportion of true negatives out of actual positives. When controlling the FDR, one
need to control the sensitivity or FNR. Setting FDR too low means that FNR is high.
This means that the chance of including truly differentially expressed genes as not
differentially expressed is high. So, FDR must be accompanied by sensitivity. Factors
determining FDR:
1. Proportion of truly differentially expressed (DE) genes
2. Distribution of true differences
3. Measurement variability
4. Sample size.
What is the relation between sample size and FDR ? Any statistical testing pro-
cedure applied on the gene by gene basis is characterized as follows:
• Compute the relevant test statistic for each gene
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• Sort the statistic in order
• Determine a cut-off point beyond which all the genes are significant
Pawitan et. al. [32] has shown that, if we declare top (1−p0)×100% as DE genes,
then FDR=FNR. For a microarray test, generally one expects FDR = FNR. Now
to answer the question : To answer how the sample size affects the different rates
(i.e. FDR, FNR, sensitivity), they proved that, as the sample size increases then the
FDR decreases and the sensitivity (power) increases. FDR and sensitivity totals 1,
so FNR decreases as the sample size increases. Given a true proportion of not-DE
genes, the paper discusses the different rates as a function of the critical values. It
then discusses the effect of sample size on the different rates. Again it discusses the
different rates as the function of percentage of significant genes ( obtained according
to the top ranking genes). When one declares a small proportion of top genes as
differentially expressed, it can lead to low sensitivity / large FNR. Sensitivity of a
test increases with the number of samples per group. One can get high sensitivity
declaring more proportion of top genes, but the small FNR has to pay a price for high
FDR. So, declaring few top genes as DE is not only the solution of the problem of
gene selection. What should one expect if one declares genes in the basis of critical
values, as in t-statistic? When one declares genes on the basis of two sided test and
critical values like t-test, then again the problem is due to the high FDR. In this case
one must have big enough sample size to get high sensitivity and low FDR. It does
not work for the small sample sizes like 5 samples per group but works well for 30
samples per group. Furthermore, it depends on the true proportion p0 of non-DE
genes. If p0 is 0.99, this method also does not produce the satisfactory result even for
sample size is large. But, on the other hand, if p0 is small, say 0.9, then it works well.
If one chooses the method of fold change, one must choose the fold change of at least
3 times standard deviation to get better result.
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1.11 Conclusion
In this chapter we have reviewed the literature about the microarray data analysis.
The basic concepts of microarray data, how the expression of genes are measured
and how these data are useful for identifying the differentially expressed genes. We
have revisited some of the tools to analyze these data, why the microarray data is
difficult to analyze and simple statistical tool is not effective for analyzing such a data.
Furthermore, we have introduced the factors that should be taken care into account
while identifying the differentially expressed genes.
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Chapter 2
Behrens-Fisher distribution for selecting Differentially expressed Genes
2.1 Summary
In this chapter, we will derive an expression for the test statistics in the case of het-
erogenous variances in the two samples using the Behrens Fisher distribution. Since
the sample variances obtained from the microarray data are not a better estimates
of the population variances, we use the priors for the estimation of variances. Then
we compare the powers in the case of equal and unequal variances and study the
effects of the variance in calculating the test statistics for the thousands of genes. We
have compared the proposed method with other existing methods such as the equal
variance method of Fox and Dimmic [13], the data dependent method of SAM [48],
simple two sample t-test [4] and LIMMA [41] for the small sample size settings.
2.2 Introduction
The two sample t-test is one of the most popular methods for testing the difference
between two samples [1], [13],[48]. There are different versions and variants of these
tests: non-parametric and Bayesian version. In such tests, one is primarily interested
on the identification of differentially expressed genes under two different conditions,
so that those particular genes of interest are further studied. Most of the existing
methods used in the literature for identification of differentially expressed genes are
two-sample t- tests [35], [17], [1], [48] and its variants, SAM [48] and regularized t-test
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[1]. In the t-test, the variances of each of the genes in account together with the means.
In this test, a gene is said to be expressed if |t| exceeds a certain threshold depending
on the confidence level selected. Since the distance between the sample means are
standardized by the variances, this approach is better than the fold-change method.
The gene expression data shows that there is an inherent limitation behind using the
simple two-sample t-test. The variances of the genes depends on the expression level
[35], [1], [48]. To identify the genes that are actually expressed, one should consider
this fact. This fact was considered in the earlier works [17], [48].
There are two inherent problems in microarray experiments: First, the number
of replications is very small, and second the number of genes to be tested is usually
large and the test is to be repeated thousands of times. Since the small population
size is very common in microarray studies, the sample estimates of variances are not
appropriate for the testing. The variance of genes depends on the expression level
[48], [35], [1]. Therefore, we have to consider the Bayesian approach to approximate
the variances in two conditions. To remove the second defect arising from multiple
comparison, we use the False Discovery Rate (FDR) correction [54]. Applying the hy-
pothesis test repeatedly gene by gene for several thousands of genes, there is a great
chance of selecting false genes as differentially expressed, even though the significance
level is set very small. For the test to be reliable, the probability of selecting true
positive should be high. To control the false positive rate, we have applied the FDR
correction, in which the p -values for each of the gene is compared with its corre-
sponding threshold. A gene is, then, said to be differentially expressed if the p-value
is less than the threshold.
The Behrens - Fisher problem arises when one seeks to make inferences about the
means of two normal populations without assuming the variances are equal. But, in
many practical situations the populations do not have same variances. Although the
Satterthwaites t-test deals with the unequal variances case, the degrees of freedom is
small and hence it does not produce better estimate of the variances [1]. Here, we
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briefly review the two sample t-test and introduce the proposed Behrens Fisher (BF)
distribution.
Let x = (x1, x2, ..., xm) and y = (y1, y2, ...., yn) be two independent samples from
two normal populations with means µx and µy and equal variances σ
2
x = σ
2
y = σ
2
respectively. If x¯ and y¯ are means; s2y and s
2
y are variances of x and y respectively;
and s2 =
(m−1)s2x+(n−1)s2y
m+n−2 is the pooled sample variance, the two sample test statistic
is given by
t =
δ − (y¯ − x¯)√
(1/m+ 1/n)s2
is distributed as student’s t-statistic with (m+ n− 2) degrees of freedom.
Now, let the samples x and y are from normal distributions with unequal variances
σ2x and σ
2
y respectively. In this case neither a pivotal statistic nor an exact confidence
interval procedure exist [23]. We can take a statistic
t∗ =
δ − (y¯ − x¯)√
s2x/m+ s
2
y/n
∼ t[min(ν1,ν2)]
where, ν1 = m − 1, ν2 = n − 1. If the sample sizes m and n are large, then the
both t and t∗ statistics give almost the same result. In the microarray experiments
the sample sizes are relatively small, thus motivating us to look for an alternative.
2.3 Multiple Testing
To select the differentially expressed genes from thousands of genes, there are thou-
sands of hypotheses each belonging to each gene. So the hypotheses must be tested
simultaneously. For this, the hypothesis tests should be run thousands of times re-
peatedly. A problem with doing so many tests is that the number of false positives
may be increased. This phenomenon is called multiple testing. The simultaneous
hypotheses is:
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Number of Genes Declared non-DE Declared DE Total
True non DE U V m0
True DE T S p−m0
p−R R p
Table 2.1: Multiple testing Procedure in Simultaneous Hypothesis Testing
H0 :

Gene 1 is not differentially expressed
Gene 2 is not differentially expressed
....... ..... ............
Gene p is not differentially expressed.
(2.3.1)
H1: At least one Gene is differentially expressed.
While testing the simultaneous hypotheses, one gets the number of hypotheses as
in the table. Similar to testing a single hypothesis, the idea here is to control the
number of false positives, V . This number is a random variable whose value differs
from one test to another test. Let α be the type-I error that one makes when testing
for a gene i. Then, α = Probability of rejecting H0 in fact H0 is true. In terms of
above hypothesis, α= Probability of selecting a false gene as differentially expressed.
Such a gene is called a false positive. So, expected number of selecting false positives
from a set of p genes is αp. In other words, since p is very big integer, the number of
false positives in the experiment is very big, even though we choose α very small.
This means that, probability of not selecting a false gene as differentially expressed
= 1− α. In other words, probability of making the right decision for a gene = 1− α.
Hence, the probability of making correct decision for all p genes = (probability of
making correct decision for gene 1).(probability of making correct decision for gene
2).........(probability of making correct decision for gene p) is (1 − α)p. From this we
see that, as p increases, the probability of making correct decision decreases. So, the
probability of at least one false positive somewhere is:
Type I Error = 1− (1− α)p (2.3.2)
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This Type I Error is also called the family-wise error rate (FWER). There are few
approaches to minimize the family-wise error rates. If the FP Rate is the error mea-
sure used, then a simple p-value threshold of α guarantees that the expected number
of false positives, V , when testing all p hypothesis/genes is E(V ) ≤ αp.
1. Sidak and Bonferroni Correction
This multiple correction method is one of the earliest method introduced by Bon-
ferroni [54]. Let p be the number of tests performed for each gene. Let us consider a
problem of achieving a global significance level α. Now the question is what value of
gene-wise significance level αg should be specified to achieve this goal ? From (2.3.2),
this means that,
rectionα = 1− (1− αg)p
or, αg = 1− (1− α)
1
p (2.3.3)
The above equation(2.3.3) is called the Sidak Correction for multiple testing. This
means that if we want to achieve the global significance level αg, we have to set the
significance level for each gene as 1 − (1 − αg)
1
p . Expanding the (2.3.3) by Binomial
theorem and taking the first two terms we get the Bonferroni Correction :
α = 1− (1− αg)p = 1− (1− pαg + ...) = pαg (2.3.4)
or,
αg =
α
p
(2.3.5)
This means that instead, we have to set the significance level as α divided by
the number of genes (tests to be performed). In other words, if the error measure is
FWER, then the probability that at least one false positive gene will be selected by
the rule when we set αg =
α
p
does not exceed α. From the above, the significance
levels are the same for each gene, no matter of their p-values. To avoid the situation
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the following method was proposed.
2. Holm’s Step-wise Correction:
While the Sidak and Bonferroni approaches [54] are effective to avoid too many
false positives, but the worst that can happen is : we get none of the genes signifi-
cantly expressed because we take the same significance level for all tests (genes) and
the significance level αg
p
is too small for large p. So, this method is too conservative in
the sense that it selects the only strong truly DE genes. Because of large number of
hypotheses, p, there is many false positive by chance, it is more appropriate to choose
the significance level for a gene according to its p-value. This method adjusts more
to the genes that have smaller p-values than on larger p-values.
Algorithm:
1. Choose the global significance level α.
2. Order the genes according to their p-values in ascending order.
3. Compare the p-value (pi) of the i-th gene in the ordered list with the threshold
τi =
α
p−i+1 .
4. Report the gene i in the order as significantly expressed if pi < τi.
Here, what we see is that the threshold for the genes is chosen according to their
p-values. If the p-value for a gene is smaller then the order i is smaller. Hence τi is
also smaller. This makes more sense than the uniform significance level.
2.4 Measures of Erroneous Rejection of Null Hypotheses
There are two measures of false decision in the multiple testing context as described
in [54]:
1. Familywise Error Rate (FWER)
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2. False Discovery Rate (FDR)
The FWER is defined as the probability of at least one false positive:
FWER = Prob(V ≥ 1).
The false discovery rate is defined is given by
FDR = E
[
V
R
|R > 0
]
× Prob[R > 0].
where, V = number of false positives; R = V + S, number of positive findings.
Generally, FWER ≥ FDR. Equality holds if all null hypotheses are true. But,
in practice, some null hypotheses are actually false, hence FDR control is less strict
than the FWER control, hence it has more power [52]. So, instead of controlling
the FWER, Benjamini and Hochberg [3] proposed a method to control the FDR.
The FDR is estimated by the permutation scheme. Depending on the chosen cut-off
value(s) α for the test statistic Tg one can estimate the FDR as follows:
• Estimate the number of non-differentially expressed genes, m0. This can be done
in the following way:
– Calculate the p-values for each of the genes. A gene g with pg > 0.5 is
usually not differentially expressed.
– Since the p-values of non-differentially expressed genes should be distributed
uniformly on [0, 1], the estimate of m0, mˆ0 = 2 ∗#{g : pg > 0.5}.
• Compute the number of significant genes under permutations of the sample
labels. The average of these numbers, multiplied with mˆ0/N gives an estimate
of the expected number of false positives, Ê(V ).
• Estimate FDR of that test, E(V/R) by Ê(V )/R.
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In other words, if α be the significant level of the test,m0 be the truly non-differentially
expressed genes and R be the declared differentially expressed genes, then
FDR =
α×m0
R
.
If all the null hypotheses were true, then the FDR is equal to the familywise error
rate. However, this rarely happens in reality. In general, the more the number of
hypotheses that are truly false, the smaller is the FDR. Therefore, the control of FDR
tends to be more relaxed than control of FWER at the same level of significance. To
determine the differentially expressed genes using the FDR procedure, one uses the
following steps:
• Choose the global significance level α
• Order the genes according to their p-values in the increasing order.
• Compare the p-values (pi) of the i-th gene in the ordered list with threshold
τi =
i
p
α.
• Report those genes i as differentially expressed which satisfies pi < τi.
Storey and Tibshirani [43] noted that an adjustment is only necessary when there
are positive findings, i.e. there are cases when the null hypotheses are rejected. They
proposed the modified version of the FDR, called the positive false discovery rate
(pFDR):
pFDR = E[
V
R
|R > 0]
Since the number of false positives are unknown, we have to estimate V in order to
estimate pFDR. Suppose we have a dataset of N genes in two conditions replicated n1
and n2 times. Then change the class labels by permuting each gene B times. Suppose
that the average number R∗ of genes have the p-values smaller than threshold α
(where α is the genewise significant level) over the B permutated data sets.Then the
estimate of the pFDR is:
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pFDR =
R∗
R
Since the calculation of FDR is based on the gene scores from permutations of
the data, the correlation in the genes are accounted for. Use of the permutation
distribution avoids the parametric assumptions about the distribution of individual
genes. Hence, the FDR criteria of selecting genes is usually better than the FWER
criteria of selecting genes, because FDR takes account of correlation among the genes
and it is more powerful.
2.5 Two-Sample Permutation Test
In the two sample t-test, one requires the following three assumptions:
• the samples are randomly selected from two populations
• the populations have normal distributions; and
• the variances of two populations are same.
If anyone of the above assumption fails, then it is likely that t - test can not give more
accurate result. Furthermore, the sample size in the microarray experiment is usually
too small. So, the random assignment of the observed intensities of each gene i in two
different conditions provides the basis for drawing statistical inference about the effect
of the treatment over the normal condition. The argument goes as follows: Consider
a single gene i. If there is no difference between normal and treatment conditions
(i.e., it expresses similarly in both conditions), then assigning randomly all the values
obtained between two conditions would have an equal chance of being observed in the
study.
For example, let there are 3 values under normal condition and 2 values under
treatment condition of gene i. Then there are C(5, 2) = 10 combinations of different
genes altogether, in each conditions. These are the types of datasets one would expect
to observe if the gene i under two conditions are equally expressed. Since we have
permuted the label of each gene in two conditions, we expect that the mean of two
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samples are equal. This means we can use the difference of means as the test statistic.
Let Dobs be the difference between two observed sample means. Then we have 10
different means of differences D of permuted samples. Then for the two-tailed test,
the p-value for the gene i is given by:
pi =
number of |D|′s ≥ |Dobs|
number of permutations
With this p-value, reject the null hypothesis at the level of 5% significance level,
i.e. if p-value < 0.05.
2.6 Significance Analysis of Microarrays (SAM)
Although the permutation based approach proposed by Westfall and Young (1991)
[51] defines weak control of the error rate and considers the correlation among genes,
it is still too stringent to their data. In their experiment, they identified either zero
or 300 significant genes depending on how the p-value is corrected. To address the
above challenges, Tusher et al.[48] proposed the Significance Analysis of Microarray
(SAM) . Basically, SAM assigns a score for each gene according to the change in gene
expression. Genes with greater than the threshold is considered to be potentially
significant. To control false positives, SAM uses the permutation of measurements to
estimate the pFDR [48]. The score threshold for genes is then adjusted iteratively
according to the pFDR until a set of significant genes have been identified. To each
gene i, SAM assigns a score
d(i) =
x¯1(i)− x¯2(i)
s(i) + s0
, (2.6.6)
where x¯1(i) and x¯2(i) are the average level of expressions for gene i in the classes 1
and 2 respectively. If there are n1 and n2 replications of gene i in two classes,
s(i) =
√
(n1 − 1)s21 + (n2 − 1)s22
n1 + n2 − 2
Compared to t-statistic, the SAM’s score adds a ”fudge” term, s0, in the denom-
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inator.The reason behind it is, the variance s(i) tends to be smaller at the lower
expression levels. This makes the score d(i) dependent in s(i). To compare the values
of d(i) across all genes, the distribution of d(i) should be independent of expression
levels and hence independent of s(i). To address this problem, SAM seeks to find the
fudge factor s0 such that the dependency of d(i) with s(i) is as small as possible. Such
an s0 is obtained by certain percentile of si values depending on the data. The FDR
in the SAM procedure is obtained by the permutation method, which is different than
the Benjamini and Hochberg procedure. It is given by
pFDR =
1
B
∑B
b=1Cb
C
where B is the number of permutations of samples, Cb is the number of potentially
significant genes in the b-th permutated data set, and C is the # of potentially
significant genes in the original data set.
2.7 Sampling Distribution for Non-homogeneous Variance
2.8 Bayesian Approach
In the following, we are going to derive the marginal posterior distribution of the
difference of two population means from two samples with different variances. We
have taken the priors as in [1], and we have compared the result with the existing
method [13]. Since there are few samples in the microarray data, all the information
required to estimate the parameters are not sufficient. So, as in Baldi and Long [1]
and [13], the Bayesian approach has been proposed to estimate the distribution and
estimate the parameters.
For the samples x = (xi)
iid∼ N(µ, σ2) and y = (yj) iid∼ N(µ + ∆µ, τ 2),where,
i = 1, 2, ....,m; and j = 1, 2, ...., n.
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The density for x = (x1, x2, ., ..., xm) can be written as ,
f(x) =
1
σm(2pi)
m
2
exp
[−1
2σ2
{(m− 1)s2x +m(x¯− µ)2}
]
(2.8.7)
Similarly, the density of y is,
f(y) =
1
τn(2pi)
n
2
exp
[−1
2τ 2
{(n− 1)s2y + n(y¯ − µ−∆µ)2}
]
(2.8.8)
The frequentist approach requires a large number of observations before making
the probabilistic judgements about the outcomes. In the microarray data, the sam-
ple size is small thus it underestimates the population variance and gives unreliable
estimate of the population variance. Classical statistics are directed towards the use
of sample information in making inferences. But in Bayesian analysis, one combines
the information obtained from sample and other relevant aspects of the problem in
order to make the best decision. So, we use the bayesian analysis for estimating the
variances. For microarray data the conjugate prior seems to be more suitable and
flexible because of its convenient form. Assuming the independency of the location
parameter µ and scale parameter σ2 as in [13], the joint prior for µ and σ2 is the
product
p(µ, σ2) = p(µ)p(σ2) (2.8.9)
Similarly, the joint prior for µ+∆µ and τ 2 is
p(µ+∆µ, τ 2) = p(µ+∆µ)p(τ 2) (2.8.10)
Finally, the joint prior for µ, σ2, µ+∆µ, τ 2 is
prior = p(µ, σ2, µ+∆µ, τ 2)
= p(µ)p(σ2)p(µ+∆µ)p(τ 2) (2.8.11)
Since (x¯, s2x) and (y¯, s
2
y) are sufficient statistics for (µ, σ
2) and (µ+∆µ, τ 2) respectively,
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we have the joint posterior distribution is given by the Bayes’ Rule [15],
p(µ,∆µ, σ2, τ 2|x,y) ∝ (prior) 1
σmτn
exp
(−Cµ
2σ2
)
exp
(−Dµ+∆µ
2τ 2
)
(2.8.12)
where,
Cµ = (m− 1)s2x +m(x¯− µ)2;
Dµ+∆µ = (n− 1)s2y + n(y¯ − (µ+∆µ))2
We obtain the marginal posterior density of (∆µ, σ2, τ 2) by integrating (2.8.12)
with respect to µ. The marginal posterior is
p(∆µ, σ2, τ 2|x,y) ∝
∫ ∞
−∞
(prior)
[ 1
σmτn
exp
(−Cµ
2σ2
− Dµ+∆µ
2τ 2
)]
dµ (2.8.13)
Let us assume that the priors for µ and µ +∆µ are flat priors, i.e. p(µ) = 1, p(µ +
∆µ) = 1 and the priors for σ2 and τ 2 are scaled inverse-χ2 distributions as in [13].
The pdf of inverse chi-square distribution with df = α and scale = β2 is given by
f(x;α, β2) =
(β
2α
2
)
α
2
Γ(α
2
)
x−(
α
2
+1)exp
(
− αβ
2
2x
)
With these priors the posterior is of the same form [1]. So, they are the conjugate
priors for the normal likelihoods. i.e. p(σ2) = I(σ2; ν0, σ
2
0) and p(τ
2) = I(τ 2; η0, τ
2
0 )
where,
p(σ2) ∝ σ−(ν0+2)exp(− 1
2σ2
ν0σ
2
0) (2.8.14)
p(τ 2) ∝ τ−(η0+2)exp(− 1
2τ 2
η0τ
2
0 ) (2.8.15)
where, α = (ν0, η0, σ
2
0, τ
2
0 ) is the hyper-parameters that should be estimated from the
data.
Hence from equations (2.8.13), (2.8.14) and (2.8.15), the marginal posterior density
of (∆µ, σ2, τ 2) is
p(∆µ, σ2, τ 2|x,y) ∝ 1
σm+ν0+2
· 1
τn+η0+2
∫ ∞
−∞
exp
(
−Cµ + ν0σ
2
0
2σ2
)
exp
(
−Dµ+∆µ + η0τ
2
0
2τ 2
)
dµ
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=∫ ∞
−∞
[ 1
σm+ν0+2
exp
(
− Cµ + ν0σ
2
0
2σ2
)][ 1
τn+η0+2
exp
(
− Dµ+∆µ + η0τ
2
0
2τ 2
)]
dµ
The marginal posterior of ∆µ is obtained by
p(∆µ|x,y) ∝
∫ ∞
µ=−∞
[ ∫ ∞
0
1
σm+ν0+2
exp
(
− Cµ + ν0σ
2
0
2σ2
)
dσ2
]
.
[ ∫ ∞
0
1
τn+η0+2
exp
(
− Dµ+∆µ + η0τ
2
0
2τ 2
)
dτ 2
]
dµ
=
∫ ∞
µ=−∞
I1. I2 dµ (2.8.16)
Now,
I1 =
∫ ∞
0
1
σm+ν0+2
exp
(
− A
2σ2
)
dσ2,
where,
A = Cµ + ν0σ
2
0
Changing the variable u = A
2σ2
and after some computation, we get
I1 =
∫ 0
∞(
A
2u
)−(
m+ν0+2
2
)e−u(−A
2u2
)du
= A−
(m+ν0)
2
∫∞
0
e−uu(
m+ν0+2
2
)−2du
= A−
(m+ν0)
2
∫∞
0
e−uu
(m+ν0)
2
−1du
This being non-normalized gamma integral, the above integral is,
I1 ∝ A− (m+ν0)2
= (Cµ + ν0σ
2
0)
− (m+ν0)
2
= [(m− 1)s2x +m(x¯− µ)2 + ν0σ20]−
(m+ν0)
2
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= [1 + m(x¯−µ)
2
(m−1)s2x+ν0σ20 ]
− (m+ν0)
2
i.e.
I1 ∝ [1 + m(x¯− µ)
2
vmσ2m
]−
(m+ν0)
2 (2.8.17)
where, vm = m+ ν0 − 1, vmσ2m = (m− 1)s2x + ν0σ20.
Similarly, we get the another factor in (2.8.16) as
I2 ∝ [1 + n(y¯ − µ−∆µ)
2
wnτ 2n
]−
(n+η0)
2 (2.8.18)
where, wn = n+ η0 − 1, wnτ 2n = (n− 1)s2y + η0τ 20 .
Substituting (2.8.17) and (2.8.18) in (2.8.16), we get
p(∆µ|x,y) = k
∫ ∞
µ=−∞
[
1 +
m(x¯− µ)2
vmσ2m
]− 1
2
(m+ν0)[
1 +
n(y¯ − (∆µ+ µ))2
wnτ 2n
]− 1
2
(n+η0)
dµ
= k
∫ ∞
µ=−∞
[
1 +
m(x¯− µ)2
vmσ2m
]− 1
2
(vm+1)[
1 +
n(y¯ − (∆µ+ µ))2
wnτ 2n
]− 1
2
(wn+1)
dµ
(2.8.19)
This is the pdf of the Behrens-Fisher distribution, where k is given by,
k =
[
Beta
(vm
2
,
1
2
)
Beta
(wn
2
,
1
2
)√
vmwn
]−1
Now, we can apply the Behrens-Fisher distribution for testing the hypothesis regard-
ing the two population means, using two samples drawn from the population with
different means and different variances.
2.9 Test Statistic
Let us define the statistic, called the BF -statistic as in [5]:
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B = ∆µ−(y¯−x¯)
(
σ2m
m
+
τ2n
n
)
1
2
= (µ+∆µ)−y¯
τn/
√
n
cosθ − (µ−x¯)
σm/
√
m
sinθ
= Bycosθ −Bxsinθ
where,
tanθ =
σm/
√
m
τn/
√
n
, 0 ≤ θ ≤ pi
2
Bx =
(µ− x¯)
σm/
√
m
, By =
(µ+∆µ)− y¯
τn/
√
n
and, Bx and By are independently distributed as t- statistics, t(vm) and t(wn) respec-
tively. Hence, under the sampling distribution, p(x,y|µ, σ2, τ 2), the statistic B is
distributed as the Behrens- Fisher distribution with vm and wn degrees of freedom.
That is,
B ∼ BF (vm, wn, θ)
with pdf
f(β|µ, σ2, τ 2) = k
∫ ∞
−∞
[
1 +
(αcosθ − βsinθ)2
vm
]− vm+1
2
[
1 +
(αsinθ + βcosθ)2
wn
]−wn+1
2
dα,
(2.9.20)
where,
α = Bysinθ +Bxcosθ, β = Bycosθ −Bxsinθ
which is same as (2.8.19). Hence, we have proved the following :
Theorem: Let x and y be two independent samples with sample sizes m and n
respectively from normal distributions with different means µ and (µ+∆µ) and vari-
ances σ2 and τ 2. If the priors ν0 and η0 for means are flat priors and priors for
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variances σ20 and τ
2
0 are scaled inverse χ
2- distributions, the posterior distribution of
∆µ is the Behrens-Fisher distribution with vm = m+ ν0 − 1, wn = n+ η0 − 1 degrees
of freedom.
Due to the complexity of the pdf of the BF-distribution as given in (2.9.20), it
is very hard to compute the corresponding probabilities, especially due to the possi-
bility of the fractional degrees of freedom. In addition, there are no uniformly most
powerful unbiased tests for all sample sizes for the BF- problem [4]. Because of this,
there are various types of approximations available in the literature [31],[4]. Due to
the simplicity of application as well as availability of R-code (www.r-project.org) for
computing t- values even for fractional degrees of freedom, we use Patil’s approxima-
tion [31] in this work as follows.
Let
f1 =
(
wn
wn−2
)
cos2θ +
(
vm
vm−2
)
sin2θ
f2 =
w2n
(wn−2)2(wn−4)cos
4θ + v
2
m
(vm−2)2(vm−4)sin
4θ
a2 = (b−2)
b
f1
b = 4 +
f21
f2
cos2θ =
τ2n
n(
τ2n
n
+
σ2m
m
) , sin2θ = 1− cos2θ.
Then, the statistic
B
a
∼ t(b). (2.9.21)
That is, B has approximately t-distribution with b degrees of freedom (b ≥ 1, b may
not be an integer [5] ) and scale parameter a. This statistic B can also be denoted as
B ∼ t(0, a2, b). It was noted [31] that the formula (2.9.21) is valid only for vm, wn ≥ 5
and works quite well for vm, wn ≥ 7 .
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The corresponding Bayesian test statistic [13] for the equal variance case is
E =
(
∆µ − (y¯ − x¯)
)
υ
√
1
m
+ 1
n
(2.9.22)
which is distributed as t distribution with δ degrees of freedom, where, δ = m+ n+ ν0 − 2δυ2 = ν0σ20 + (m− 1)s2x + (n− 1)s2y (2.9.23)
2.10 Calculation of Prior d.f. and Prior Variance
The observed dependence between population mean (µ) and population variance (σ2)
is established by calculating the prior variance (σ20) based on the variance of similarly
expressed genes. However, in this formulation, instead of taking the average standard
deviation of similarly expressed genes we choose to estimate the prior variance by
totaling the sum of squared difference for each similar genes and dividing by the total
prior degrees of freedom. This is more statistically rigorous way of incorporating prior
information and leads to more consistent test. There are many possible ways one can
choose p and q (and so prior variances and prior means) in the above expressions. In
each of the methods, we use the sample variances of only particular genes in both
control and treatment conditions, and apply equations (2.11.30),(2.11.31),(2.11.32)
and (3.4). In this work we choose p and q in the following manners and compare the
effect of each of these in terms of FDR.
2.11 Estimation of Hyperparameters
There are two different methods to estimate the hyperparameters: Empirical Bayes
(Robbins) method and Evidence Method (MacKay 1992). In the evidence method the
evidence, which is the integration of the posterior distribution of data, is maximized
with respect to the hyperparameter of interest. The reason for this is similar to
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maximising the posterior distribution under the squared error loss function L(θ, a) =
(θ − a)2 while estimating the parameter θ by a. The evidence method has been used
to estimate the parameter. We take the estimate of degrees of freedom from m control
samples as νˆ0 = m− 1, and from n treatment samples as ηˆ0 = n− 1. The evidence is
given by the integral
P (x|ν0, σ20) =
∫ ∞
µ=−∞
∫ ∞
σ2=0
1
σm+ν0−2
exp{− 1
2σ2
[(m− 1)s2x +m(x¯− µ)2 + ν0σ20]}dσ2 dµ
(2.11.24)
Writing
σ2 = u,
m+ ν0 − 2
2
= a, (m− 1)s2x + ν0σ20 = b and µ = v,
the integral (2.11.24) reduces to
P (x|ν0, σ20) =
∫ ∞
v=−∞
∫ ∞
u=0
1
ua
exp{− 1
2u
[b+m(x¯− v)2]}du dv
=
∫ ∞
u=0
1
ua
[∫ ∞
v=−∞
exp{− 1
2u
[b+m(x¯− v)2]}dv
]
du
=
∫ ∞
u=0
1
ua
exp
(
− b
2u
)[∫ ∞
v=−∞
exp{− 1
2u
[m(x¯− v)2]}dv
]
du
Integrating the interior integral and simplifying, we get the above integral as
P (x|ν0, σ20) =
∫ ∞
u=0
1
ua
exp
(
− b
2u
)[√
4piu
m
]
du
=
√
4pi
m
∫ ∞
u=0
1
ua−1/2
exp
(
− b
2u
)
(2.11.25)
Substituting b
2u
= z in the above integral and changing the limit, we get
P (x|ν0, σ20) =
√
4pi
m
(
b
2
) 1
2
−a ∫ ∞
z=0
za−
5
2 exp(−z)dz
=
√
4pi
m
(
b
2
) 1
2
−a
K(a) (2.11.26)
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where, the integral above is unnormalized gamma, hence a function of a, K(a) > 0.
After replacing the value of a and b, we get
P (x|ν0, σ20) =
√
4pi
m
(
(m− 1)s2x + ν0σ20
2
) 1
2
−m+ν0−2
2
K(
m+ ν0 − 2
2
) (2.11.27)
Differentiating with respect to σ20 and equating it to 0, we get
∂P
∂σ20
= 0
σ20 =
(m− 1)s2x
ν0
σˆ20 =
∑m
i=1(xi − x¯)2
νˆ0
(2.11.28)
Similarly, the estimate of τ 20 is obtained as
τˆ 20 =
∑n
j=1(yj − y¯)2
ηˆ0
(2.11.29)
For estimating the number of similarly expressed genes, we have the following
three methods:
Method 1: Window Method
The window method was introduced by Baldi et al.[1]. In this method, we cal-
culate the prior degrees of freedom and prior variances by taking those genes that
are similar in variances to that of the gene of interest both in control and treatment
condition within pre-chosen window size. To calculate the prior variance of a gene g
in control condition, we calculate its variance in control condition. Then we calculate
the variance of all other genes and take only those p genes whose variances are close
to that of gene g. Now the prior variance for gene g is the mean of variances of
these p genes in control condition. Similarly the prior variance for gene g in treat-
ment condition is calculated by taking q genes with similar variances to that of gene g.
For each gene g, the prior variances and prior means will be different. We have
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dropped the subscript g from them. For p genes with similar variances and each
having m replicates in control condition, the prior degree of freedom for the variance
can be calculated as,
νˆ0 = p(m− 1) (2.11.30)
Similarly, for q genes with similar variances and each having n replicates in treatment
condition, the prior degrees of freedom for the variance is given by
ηˆ0 = q(n− 1) (2.11.31)
The prior variances for control and treatment conditions are calculated as sample
variance of similar genes, which are the means of variances of similar genes in these
two conditions respectively.
σˆ0
2 =
1
ν0
p∑
k=1
m∑
i=1
(xk,i − x¯k)2 (2.11.32)
τˆ0
2 =
1
η0
q∑
k=1
n∑
j=1
(yk,j − y¯k)2 (2.11.33)
where,
x¯k is the mean response of gene k in the control condition
y¯k is the mean response of gene k in the treatment condition
xk,i is the response i of gene k in the control condition
yk,i is the response i of gene k in the treatment condition
Method 2: Similar Variance Method
In the following, we present the a method of estimating hyperparameter.
Another method is to choose the genes that have the absolute difference of vari-
ances in both control and treatment group using some cut-off values, so that we will
have certain level of confidence choosing them. For a gene g, let s2cg and s
2
tg be the
sample variances in control and treatment conditions respectively. Then choose pg=
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number of genes j such that |s2cg − s2cj| ≤ k. We choose k by the 95% CI for the
population variance, which uses the χ2 distribution to find the confidence interval.
So, k = |min{s2cg − 95% Lower χ2 CL of s2cg, s2cg − 95% Upper χ2 CL of s2cg}| in the
control condition. Similarly, choose qg = number of genes j such that |s2tg − s2tj| ≤ k,
where k = |min{s2ct − 95% Lower χ2 CL of s2ct, s2ct − 95% Upper χ2 CL of s2ct}| in
the treatment condition. So, in this method the values of p and q varies according
to each gene. By choosing the number k in such a way we are 95% confident that
the genes used for the calculation of prior variance and the degrees of freedom have
similar variance to the gene g. For simplicity, we omit the subscript g in the notation.
This method was proposed by us.
Method 3: Resampling Method
To estimate the precision of sample statistics by using the subsets of available
data by drawing randomly with replacement resampling method is used Good [?].
In the case of estimating variances, instead of taking those genes which have similar
variances within a window or as in similar variance method,we have used this method
to calculate prior variances for the actual data. Because, in the window method the
researcher should consider all possible window size and the determination of it may
be time consuming. On the other hand, the similar variance method selects huge
number of genes and so the computation time is exponentially increased. We take
the p = q = 1% bootstrap samples from the pool of all genes together with the gene
of interest from the control and treatment conditions respectively to determine the
prior d.f. and variance for a gene. Then for p genes each having m replicates in the
control condition, the prior degrees of freedom is given by ν0 = p(m−1) and the prior
variance σ20 is estimated by the variance of the p bootstrap samples in the control
condition. The prior degrees of freedom in the treatment condition η0 = q(n− 1) and
variance τ 20 are calculated similarly from the treatment condition.
The algorithm for selecting the differentially expressed genes consist of the follow-
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ing steps:
• Use the method of Dudoit et al [10] to pre-process the data, filter the genes, and
normalize the data.
• Take the control group of the training sample.
• Calculate the variances of each gene.
• Set the bounds for error: For each gene g
lower bound = Variance of g − Error
upper bound = Variance of g + Error
Error =
1
2
(Vmax − Vmin)
where, Vmax = maxgVariances and Vmin = mingVariances
• Choose those variances that are in between lower and upper bound and take a
mean of those variances to estimate the prior variances. This gives the variances
of each gene as the mean of those variances which satisfy the similar variance
criteria in the training samples.
• Repeat the above 5 procedures in the control group of test sample.
2.12 Simulation and Result
To implement the theory, we have simulated 10,000 genes from normal distributions
having mean µ1 variance σ
2
1 in the normal conditions and mean µ2 and variance σ
2
2 in
the treatment conditions that was found as in Golub data. Each gene was replicated
10 times in each of the control and treatment conditions. Without loss of generality,
we have set the first 2 percent of the genes as differentially expressed. The assump-
tions that we made to simulate the data were they are independent and normally
distributed.
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1. Out of 10,000 genes, simulate 98,00 genes from a normal distribution with mean
µ ∼ U [0, 1] and variance σ2 ∼ Inv − χ2(df = 20, scale = 2).
2. Without loss of generality, simulate first 100 genes from normal distribution with
mean µ ∼ U [5, 10] + 1
2
and variance σ2 ∼ Inv − χ2(df = 20, scale = 4) in the
control condition and mean µ ∼ U [5, 10] − 1
2
and variance σ2 ∼ Inv − χ2(df =
18, scale = 6) in the control condition.
3. Simulate another 100 genes from normal distribution with mean µ ∼ U [5, 10]− 1
2
and variance σ2 ∼ Inv − χ2(df = 18, scale = 6) in the control condition and
mean µ ∼ U [5, 10] + 1
2
and variance σ2 ∼ Inv − χ2(df = 18, scale = 4) in the
control condition.
In the simplest case, when we choose ν0= η0 = 0, then the BF statistic reduces to
the two sample t-test. The parameters ν0 and η0 represents the degree of confidence
in the background variances σ20 and τ
2
0 versus the empirical variances of control and
treatment respectively. We have chosen the values of these two variances in the
wide range beginning from 0. The values of ν0 and η0 are increased. In each of
the calculation of variances of similar genes in the two conditions, we have taken
the window size equal to the the replicates in each condition, i.e., taking p/2 genes in
control group immediately above and below the gene under considerations. The mean
is taken of those ordered variances corresponding to the gene of interest. Since the
Behrens-Fisher distribution does not give the good result unless vm and wn is greater
than 5 and gives very good result when it exceeds 7 [31], we have chosen the values
of the prior degrees of freedom such that vm and wn exceeds 7. We have chosen those
genes as differentially expressed whose p-values are smaller than ranked values of the
statistic given by FDR criterion. Furthermore we have chosen the level of significance
α = 0.05. The number of genes that are found differentially expressed in our method
and in the equal variance cases are compared in Table 2.2. We have run the data 5
times and averaged the number of genes selected as differentially expressed in each
time. In analyzing the fold change method with the BF method, we have found that
all the genes associated with the large - fold change are not necessarily statistically
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significant in the Bayesian BF method.
2.13 Power Comparisons
Here, we have compared the power obtained by our method with that of equal variance
test of Fox-Dimmic [13]. The application of treatment not only affects the averages
but it affects the expression measurements, so it affects variances as well. It is a
common experience in statistical analysis that as the number of samples increases,
the power of the test also increases. But in our case, the power depends on the priors
as well. Even for the small values of priors, the power of the proposed method seems
optimum than the equal variance method.
The power of a test is defined as the probability of rejecting the false null hypoth-
esis. If β is the probability that a true alternative hypothesis is falsely rejected, then
the power of that test is given by 1− β. The power depends on the sample size, the
sample standard deviation and the difference of the null and alternative hypothesized
mean. We have chosen the standardized effect, µ1−µ2
sd.error
as 2 for power calculation.
We see from the graph of power in Fig. 2.1 and power comparison in Table 2.2
that, at small values of ν0 the power obtained by the equal variance test is preferred
than our method. But, eventually, our proposed method seems to have better result
because we have considered the unequal variances in the two samples. In small values
of m and ν0, the corresponding values for vm = m+ ν0− 1 are smaller and it does not
give appropriate values unless it exceeds 7. Similarly, for the small values of wn. So,
we have to choose the values of ν0 or η0 and m or n such that the values of vm and
wn is at least 5. Holding ν0 = η0 = 4 we see the difference of power in EV method
and the new method increases significantly as the sample size increase from 2 to 5.
The difference in the power between this proposed method and the EV method is
less pronounced for the small sample sizes and small values of the prior degrees of
freedom. But it is more distinct as the prior degree of freedom increases. We have
chosen the prior variances σ20=0.7 and τ
2
0=0.3.
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Figure 2.1: Power comparison for different sample size and priors using Method 1
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The Figures 2.2 and 2.3 show the power comparison of the proposed BF method
and the method used by the Fox and Dimmic in the case of samples of sizes 3 and 5.
In this small sample case, the power of the proposed BF method is found to be larger
than the Fox-Dimmic method. The Fig. 2.4 is the graph of the proposed Behrens-
Fisher test. The line in this grah is the cut-off for controlling the false discovery rate
of 0.05. The points below the line is the genes that are differentially expressed.
In this simulated study, we have used the proportion of genes that are actually
differentially expressed and detected by our method as the criterion for comparing
the proposed method. As this method is not suitable if there is small values of m or n
and p or q that makes vm and wn small, which is seen clearly from the table (Table 2)
that for m = n = 2 and choosing any values of the priors ν0 and τ0 only selects 10%
of the genes that are actually expressed, although it reports large amount of genes
as differentially expressed. We have found that the genes marked as differentially
expressed by the fold-change (fold change = 2) method is almost 32% of the total
number of genes included in the simulated study. This result is highly unacceptable
as we have assumed only 2% of the genes as differentially expressed. On the another
extreme, we ran two-sample t-test and found that it selected few genes as differentially
expressed as the sample sizes was increased to 4 and the window size was 20. After
that it selected many genes and the result was getting better when we took sample
size of 10. In this case, it selected almost the same genes as our method. So, this
method failed for the small sample size, because it could not select the genes that are
actually differentially expressed.
2.14 Comparison of DE Genes using the Window Method with Other
Methods
Table 2.3 compares the different methods with the proposed method. All three tests,
except fold-change method, gave almost the same conclusion as our proposed method.
Initially, when the sample size and window size both are small, m = 2 and p = 2,
46
m = n ν0 = η0 power BF Power EV
2 16 0.5617153 0.4532222
3 16 0.7179875 0.6035196
4 16 0.820609 0.7177347
5 16 0.8865956 0.8020212
2 8 0.4969753 0.4067113
3 8 0.6431226 0.5496432
4 8 0.7496756 0.6657278
5 8 0.8262618 0.7566512
2 4 0.3985896 0.3444951
3 4 0.5350779 0.4867308
4 4 0.6495701 0.6098946
5 4 0.8395813 0.7105832
2 2 0.3057716 0.2803869
3 2 0.4221825 0.429857
4 2 0.545814 0.5631983
5 2 0.6547838 0.6739527
Table 2.2: Table of Power Comparison
then the method of equal variance test seemed better in terms of proportion of actual
genes selected. This is natural because our method does not give the better result
for small values of vm or wn. However, as we have greater values of sample size and
window size, our method excels the equal variance Bayesian test counterpart. We
have seen from the result that almost all of the actually DE genes were selected by
this proposed method when m = n = 10 and p = q = 8. But, the proportion of genes
selected compared to the actual set of DE genes is just 75.7%.
The maximum proportion of genes selected is 88.7% when m = n = 10 and
p = q = 2. In this case all of the genes actually DE are selected. Our method and
equal variance test selected almost the same number of genes on average. Unless
p = q = 8 and for m = n = 2, both the equal variance and unequal variance method
selected enormous number of genes, most of them being bogus (false positive). The
proportion of true genes is very low, about 11%. When m = n = 3 and p = q = 2,
our method selected 45 genes of them 20 are actually DE, but equal variance method
selected about 134 genes, of them only 58 are actually DE. Hence the proportion of
true genes are 0.44 and 0.42 respectively. Taking the sample sizes constant, we found
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Replications DE genes Common in actual Proportion
m = n p = q FC t-test EV BF BF EV BF EV
2 2 3421 1 157.5 239 21.5 23 0.09 0.15
2 4 3430.5 0.5 544.5 263 35.5 61 0.13 0.11
2 8 3439.67 0 1145.67 733.33 85.33 119 0.12 0.1
2 20 3459 0 1693 1051 110 138 0.1 0.08
2 100 3374.5 0 2126.5 1187 121 154 0.1 0.07
3 2 3347 0.33 134.33 45 20 57.67 0.44 0.43
3 4 3392 0.33 344 226 79 111 0.35 0.32
3 8 3314.33 0 569.33 357.33 107.67 133.67 0.3 0.23
3 20 3371 0 832 479.67 133 158 0.28 0.19
3 100 3320.5 0.5 1032 568 135 165 0.24 0.16
4 2 3293.33 0.5 165 109.67 74.67 104 0.68 0.63
4 4 3317.4 0.33 279.4 204.4 114.8 141.4 0.56 0.51
4 8 3353.33 1.2 409 282 131 156.67 0.46 0.38
4 20 3378.5 0.67 568 364 151.5 175.5 0.42 0.31
4 100 3311 1 648.5 389 165 184 0.42 0.28
5 2 3332.33 1 208 167.33 131.33 158 0.78 0.76
5 4 3273 36.33 260 227.33 153.67 166.67 0.68 0.64
5 8 3267 23 320.5 240.5 155 176 0.64 0.55
5 20 3295 36.5 424.33 307 168.67 186.67 0.55 0.44
5 100 3251.67 51.67 453.33 326.67 174 184.33 0.53 0.41
10 2 3169 28.67 226.5 225.5 200 200 0.89 0.88
10 4 3133.67 215 245.33 242 198 199.33 0.82 0.81
10 8 3145.33 212.33 264.33 263.67 199.67 199.67 0.76 0.76
10 20 3168.33 217 269.67 264.67 200 200 0.76 0.74
10 100 3094 211.5 266.5 268 199 199.5 0.74 0.75
Table 2.3: Comparison of BF test with other tests based on the proportion of actually DE
genes selected in Window Method.
Samples DE genes Common in actual Proportion
m,n BF EV SAM t BF EV SAM t BF EV SAM t
3 , 3 22 24 11 15 15 15 11 7 0.68 0.63 1 0.47
4 , 4 24 23 20 26 19 19 19 3 0.79 0.83 0.95 0.12
5 , 5 22 22 22 29 20 20 20 19 0.91 0.91 0.91 0.66
6 , 6 23 21 20 33 20 19 19 19 0.87 0.9 0.95 0.58
10 , 10 25 23 24 36 20 19 20 20 0.8 0.83 0.83 0.56
12 , 12 23 26 23 29 20 20 20 20 0.87 0.77 0.87 0.69
15 , 15 20 20 51 34 20 20 20 20 1 1 0.39 0.59
3 , 4 29 28 16 30 18 18 16 12 0.62 0.64 1 0.4
4 , 6 24 25 24 27 20 20 20 17 0.83 0.8 0.83 0.63
10 , 15 26 26 34 37 20 20 20 20 0.77 0.77 0.59 0.54
Table 2.4: Comparision of BF test with other tests based on the proportion of actually DE
genes selected in Similar Variance Method.
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Samples Common in Actual DE Genes Selected as DE Propn. of Genes Selected
m,n BF EV SAM t BF EV SAM t BF EV SAM t
2, 2 73 63 29 15 75 63 29 115 0.97 1 1 0.13
3, 3 144 139 136 79 147 142 141 183 0.98 0.98 0.97 0.43
4, 4 179 184 175 128 182 190 179 254 0.98 0.97 0.98 0.51
5, 5 195 193 191 159 200 197 206 278 0.98 0.98 0.93 0.57
6, 6 197 198 198 188 203 203 231 325 0.97 0.98 0.86 0.58
8, 8 199 199 199 198 212 209 270 345 0.94 0.96 0.74 0.57
10, 10 200 200 200 200 209 206 332 342 0.96 0.97 0.60 0.59
12, 12 200 200 200 200 207 207 246 337 0.97 0.97 0.81 0.59
4, 3 168 170 151 94 173 173 153 230 0.97 0.98 0.99 0.41
4, 5 186 186 183 144 189 192 190 285 0.98 0.97 0.96 0.51
5, 6 198 198 198 162 201 201 215 323 0.99 0.98 0.92 0.50
6, 8 198 199 198 196 207 207 222 325 0.96 0.96 0.89 0.60
Table 2.5: Comparision of BF test with other tests based on the proportion of actually DE
genes selected in Resampling Method.
that,the number of genes selected by all three tests by Method 1 is proportional to
the window size. But, most of them were bogus, i.e, genes seem to be differentially
expressed but are not really. Even though the window size is small, the proportion
of genes selected by these methods increased as window size decreased. This means
that for a fixed sample size, small values of the priors ν0 and τ0 are preferred.
To see the performance of Method II, we have simulated 1000 genes as in the
other two methods. Because it selects huge number of genes with similar variance
according to our cut-of criterion, the computation is time consuming (which may not
be good for large number of genes and low memory computer). This method compares
with the equal variance and SAM as seen from the proportion and the number of truly
differentially expressed genes selected. In this case we have introduced only 20 genes as
differentially expressed. All three tests- BF, EV and the SAM were quite competitive
in this method. But, EV and BF are relatively more competitive. We see that SAM
selects very few genes when the sample sizes are small. But as the sample size was
increased to 15, it selected more genes. On the other hand, both BF and the EV
method selected almost the similar number of genes even though the sample size was
increased. The result is shown in Table 2.4.
Table 2.5 shows the number of gene selected by the Method III. We have compared
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the actual number of genes selected by different methods including SAM. We see that
the genes selected by our method is comparable to EV test and SAM. We notice that
SAM selects small number of genes relatively in the small sample sizes. Although
our BF method chooses more genes, it selects genes that are actually expressed. The
proportion of actually DE genes selected by BF method is comparable with the EV
test, and performs better than the SAM method. The number of genes selected by
different methods increases as the sample size increases. But the EV test and BF
test select more actually expressed genes than the SAM and t-test. This means the
the false positive rate of these two tests are smaller than that of SAM and t-test.
The false positive rate is defined as probability of false positives among the positive
findings. False Positive Rates for the samples having m = n = 5 are: (BF, 0.025),
(EV, 0.020), (SAM, 0.072) and (t-test, 0.42). This means that 2.5% genes selected by
BF method are bogus whereas 7.2% genes selected by the SAM method are bogus.
The false discovery rate is defined as the expected proportion of false positives among
the positive findings. So, our proposed method (Method II) seems better than SAM
and t-test while selecting the truly differentially expressed genes.
2.15 Comparison of Proposed Method with other Methods
Table 2.6 shows the comparison of aforementioned three methods. Here we have
calculated the false discovery rate (FDR), which is the expected proportion of false
positives among the positive findings; Proportion of DE genes; and False Negative
rate (FNR), which is the expected proportion of true negatives among the truly DE
genes for each sample and compared them. It has been found that the proportion of
truly DE genes in the Method III is higher than in the other two methods, taking the
same sample sizes in all three methods. This means that bootstrap method selects
more truly DE genes than other two method. Similarly, the FDR is also small in
bootstrap method than other two methods. And the FNR is smaller in method III
than in method I and comparable to that of Method II. Hence it seems that the
bootstrap method is the best method in selecting the truly DE genes than window
and similar variance method in our simulated data.
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Samples Proportion of DE Genes FDR FNR
m = n I II III I II III I II III
3 0.35 0.68 0.98 0.65 0.32 0.02 0.61 0.25 0.28
4 0.56 0.79 0.98 0.44 0.21 0.02 0.43 0.05 0.11
5 0.67 0.91 0.98 0.33 0.09 0.03 0.24 0 0.03
6 0.74 0.87 0.97 0.26 0.13 0.03 0.13 0 0.02
10 0.82 0.8 0.96 0.18 0.2 0.04 0.01 0 0
Table 2.6: Comparison of three methods ( I = Window Method, II = Similar Variance
Method, III = Resampling Method ) according to Proportion of truly DE genes selected,
FDR and FNR.
2.16 Selection of Differentially Expressed Genes in the Golub Data
The selection of differentially expressed genes in the micro-array data has been one of
the best studied area in the microarray literature. In this chapter, I am going to ana-
lyze the real microarray Affymetrix data to see whether the proposed Behrens Fisher
method competes with the other methods like Significance Analysis of Microarray
(SAM) introduced by Tusher et al. [48]), Linear Methods for Microarray Analysis
(LIMMA) introduced by Gordon Smyth [41], Bayesian t-test introduced by Fox and
Dimmic [13] and Empirical Bayes method introduced by Newton and Kendziorski
[29]. The Golub data is an Affymetrix data that consists of two types of cancers of 72
patients. This data was first analyzed by Golub et al. [16] to classify Acute Lymphoid
Leukemia (ALL) with Acute Myeloid Leukemia (AML). There are 38 ALL samples
and 34 AML samples. There are 7129 genes and 72 samples. the first step in analyzing
an affymetrix data is to pre-process the data to remove the bias and outliers because
of background effect measured when collecting the data. It distorts the outcome of
the analysis if not performed correctly. Here, I have used the preprocessing step as
follows:
1. Set floor of 100 units and ceiling of 16,000 units.
2. Filter the low quality genes.
3. Transform the data by using base-10 logarithm.
The threshold was set with floor of 100 units and ceiling of 16,000 units. A ceiling
of 16,000 units was chosen because it is at this level that we observe the fluorescence
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Figure 2.5: Histograms of Unprocessed Data Golub Data
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53
−3 −2 −1 0 1 2 3
0
5
10
15
20
Normal Q−Q Plot
Theoretical Quantiles
Sa
m
pl
e 
Qu
an
tile
s
Figure 2.7: QQ-Plot of Golub Data
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saturation of the scanner, below or above this values above this can’t be reliable
measure, and called them as outliers. Similarly a floor of 100 units was chosen to
minimize the noise and maximise the interpretation of marker genes due to the cor-
relation of genes. We have filtered out (excluded) those low quality genes that have
ratio (max/min) < 5 and (max−min) < 500 across all of the samples. To make the
data symmetrical (normal), base-10 logarithm has been used for the transformation.
Because of this logarithmic transformation, the skewed data will be almost normal
and symmetrical.
The histograms in the Figure 2.5 are the raw expression data and after logarithmic
transformation. The histogram in Fig. 2.6 are the histograms of the overall expres-
sion level of Golub data in the training and the test samples after the logarithmic
transformation. So, from the histograms we see that the overall expression patterns
in each of the samples from the two conditions are symmetrical and normal after
transformation.
2.17 Transformation and Test of Normality Assumptions
In the golub data, after the standard pre-processing step as mentioned in the above
section, the normality assumption was checked using the Goodness-of -Fit tests such
as Shapiro-Wilks test for normality [40]. The null hypothesis is the data x1, x2, ...., xn
come from the normally distributed population. The test statistic is
SW =
(∑n
i=1 aix(i)
)
∑n
i=1(xi − x¯)2
(2.17.34)
where, x¯ is the mean of samples, ai’s are constants given by
(a1, a2, ..., an) =
mTV −1
(mTV −1V m)1/2
andm = (m1,m2, ...,mn) andmi’s are expected values of order statistics, and V is the
covariance matrix of these order statistics. If the p-value of the test statistic SW is
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leess than confidence level α, then reject the null hypothesis, data come from normal.
This test can be used instead of the Kolmogorov-Smirnov test (Lilliefors test),
because some studies has shown that this test has good power in many situations than
other goodness of fit test of the composite hypothesis of normality (Shapiro, Wilk and
Chen 1960). This test is not affected by the ties in the values. In this test, we were
95% confident that the genes satisfy the normality assumption. Furthermore, those
genes which did not satisfy the normality assumption were transformed to normality
using the Yeoh-Johnson transformation [53]. It is given by
ψ(λ, x) =

{(x+ 1)λ − 1}/λ, (x ≥ 0, λ 6= 0);
log(x+ 1), (x ≥ 0, λ = 0);
−{(−x+ 1)2−λ − 1}/(2− λ), (x < 0, λ 6= 2);
− log(−x+ 1), (x < 0, λ = 2).
(2.17.35)
where, λ is a parameter, that is estimated from the data assuming the data come
from normal population using the maximum likelihood method.
The Fig. 2.8 shows the Q-Q plot of some of the genes in the Golub data before
Yeoh-Johnson transformation. We can see from the graph that the distribution of the
some of the genes are not normal. The Yeoh-Johnson transformation is similar to the
Box-Cox transformation except the former is also useful for transforming positive or
negative values. We can see from the Fig. 2.10 that the genes satisfies normality after
transformation.
Here in the following, we have computed the mean and variance of first few genes
of the Golub data [16]. We see that the variance depends on the mean expression
level. But after the estimation of prior variances, the posterior variance is stabilized
and this has the effect on selecting the actual expressed genes.
Differentially expressed genes were selected using the Behrens-Fisher (BF) distri-
bution. To overcome the false genes which arises due to the multiple testing, we have
controlled the familywise error rate (FWER) at the level α = 0.05 using the Bonferroni
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Genes Mean Var Before Var After
AFFX −BioDn− 3 at −1.01454519 0.22596073 0.281732
AFFX −BioB − 5 st −0.89731151 0.24048058 0.281736
AFFX −HUMISGF3A/M97935−MA at −1.18813202 0.10450397 0.281698
AFFX −HUMISGF3A/M97935−MB at −0.89940262 0.15503013 0.281712
AFFX −HUMISGF3A/M97935− 3 at 0.21463536 0.25394972 0.28174
AFFX −HUMRGE/M10098− 5 at 0.34598585 0.39634255 0.282684
AFFX −HUMRGE/M10098−M at 0.06783037 0.54154905 0.282492
AFFX −HUMRGE/M10098− 3 at 0.13062448 0.25132857 0.282435
AFFX −HUMGAPDH/M33197− 5 at 3.0651817 3.35897426 0.28178
AFFX −HUMGAPDH/M33197−M at 3.02290995 2.93944803 0.28182
AFFX −HSAC07/X00351− 5 at 3.13561769 2.73528247 0.281739
AFFX −HSAC07/X00351−M at 3.24042988 2.71219933 0.281805
AFFX −HUMTFRR/M11507− 5 at −0.52114347 0.48562603 0.281714
AFFX −HUMTFRR/M11507−M at −1.16505316 0.16032256 0.281698
AFFX −HUMTFRR/M11507− 3 at −0.56158528 0.10416494 0.281733
AFFX −M27830− 5 at 0.91157724 0.23132494 0.282428
AFFX −M27830−M at 1.74595905 0.94761702 0.281934
AFFX −M27830− 3 at 0.2332194 0.33217269 0.281762
AFFX −HSAC07/X00351− 3 st 1.1308924 0.39854292 0.28178
AFFX −HUMGAPDH/M33197−M st −0.7434625 0.27957232 0.281747
AFFX −HUMGAPDH/M33197− 3 st −0.4391125 0.3516393 0.281767
AFFX −HSAC07/X00351−M st −0.33299683 0.3902128 0.281778
A28102 at −0.56174915 0.35655727 0.281769
AB000115 at −0.5748046 0.40192783 0.281781
AB000409 at −1.15104296 0.05802834 0.281685
Table 2.7: Dependence of Variance on Expression level
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correction method and false discovery rate (FDR) using the Benjamini and Hochberg
method. The genes selected by the BF method is compared with other current gene
selection methods such as : SAM, LIMMA and FD methods. This method selects
most of the genes that are also selected by the other methods. SAM and LIMMA
do not require the data to be normally distributed. As seen from the table 2.8, the
proposed method is competitive to these method. It has selected the genes in the
midway between SAM and LIMMA.
Method No. of Genes Common Genes No. of genes
BF 713 BF , SAM 713
SAM 841 BF, LIMMA 670
LIMMA 678 SAM, LIMMA 678
FD 703 FD, BF 658
All 4 655 BF, LIMMA, SAM 670
Table 2.8: Comparision of Differentially expressed genes in Golub data controlling the FDR
at the level α = 0.05
2.18 Conclusion
We have proposed a new method to get the differentially expressed genes if the vari-
ances are different in samples. In all of those, our proposed method performed better
than the equal variance (EV) test (see Table 2.3) and SAM (see Table 2.4 and Table
2.5). Furthermore, we have compared the three methods based on the proportion
of truly differentially expressed genes selected, FDR , and FNR criterion (see Table
2.6) and found that the bootstrap method gave the best result among three proposed
methods. We have implemented our theory in R statistical software, http://www.r-
project.org. In the above the FDR criterion to control the false positives is preferred
than the familywise error rate (FWER) control criteria, because FDR ≤ FWER.
When some of the genes are actually not differentially expressed, then the FDR is
strict than the FWER therefore FDR controlling multiple testing procedure is more
powerful than the FWER controlling procedure [?].
In this chapter, we derived an expression for the posterior Behrens-Fisher distri-
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bution for the heterogeneous variance using the uniform and scaled inverse chi-square
priors. The theory thus derived was applied to select the differentially expressed genes
between two samples. We applied the result for the simulated data and real data.
The multiplicity problem that arises while testing thousands of hypotheses simulta-
neously was controlled using the false discovery rate. We have compared our method
of selecting the genes with other popular methods such as LIMMA, SAM and FD in
the sections 2.11 and 2.12. We have found that the proposed gene selection methods
performs better than the other mentioned methods.
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Figure 2.8: Q-Q plot of some of the genes before Yeo-Johnson Transformation
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Figure 2.9: Histogram of the T-values obtained by the BF Method
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Figure 2.10: Q-Q plot of some of the genes after Yeo-Johnson Transformation
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Chapter 3
Support Vector Machines and Other classification Methods
3.1 Summary
In this chapter we will discuss different classification methods, such as Support Vector
Machines(SVM), Weighted Vote (WV) Method, Nearest Shrunken Centroid (NSC)
Method, and Multiclass Classification Method. We have compared the classification
performance of these methods on the real and simulated data using the genes se-
lected by the Behrens Fisher Distribution in Section 3.10. The performance of these
classification methods have been compared. We have found that the classification
performance improves as we take the genes obtained by the Beherns-Fisher method.
In the simulated data, the ranking of the methods were : Weighted-Vote(WV), Sup-
port Vector Machines (SVMs), Multiclass method, Nearest Shrunken Centroid (NSC)
and Shrunken Centroid Regularised Discriminant Analysis (SCRDA) respectively. In
the real data also the Weighted Vote and Support Vector methods were the best for
classifying the tumor data that we have analyzed..
3.2 Introduction
Support vector machines (SVMs) introduced by Vapnik in 1995 [49] are a set of re-
lated supervised learning methods used for classification and regression. They belong
to a family of generalized classifiers and is considered as a special case of Tikhonov
regularization. A special property of SVMs is that they simultaneously minimize the
empirical classification error and maximize the geometric margin. Hence it is also
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known as maximum margin classifier. A learning method (classification method) is
called unsupervised if it learns (classifies) in the absence of a teacher signal. Unsu-
pervised learning method begins with a definition of similarity (measure of distance)
between expression patterns, but with no prior knowledge of true functional class of
genes. Genes are then grouped by using a clustering algorithm.
3.3 Assumptions on Classification Methods
The assumptions made by these five different methods are as follows:
• Weighted Vote: This method assumes that the data are independent and
identically distributed. It does not assume the normality
• Support Vector Machines: This method also assumes the data are indepen-
dent but does not assume any normality.
• Multiclass Method: This method assumes that the data are i.i.d..
• Nearest Shrunken Centroid : This method assumes that the data are i.i.d
from normal distribution.
• SCRDAMethod:This method also assumes that the data are i.i.d from normal
distribution.
The above five methods are the brief summary of the classification methods we
will use for the classification of samples. More about these methods can be found
on [16], [14], [47], and [49]. In these methods, the non-homogeneity of the samples
have not been used. So, one would expect that if the non-homogeneity was taken into
account, the classification method separates the data more accurately into their true
classes.
3.4 Support Vector Machines (SVM) Methods
The support vector machine (SVM) is one of the methods that has been successfully
applied to the cancer diagnosis problem in previous studies Mukherjee et al.[28], 1999;
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Ramaswamy et al., 2001)[34]. In this method, one finds the separating hyperplane
f(x) = b+w′x (3.4.1)
from the training samples {(x1, y1), (x2, y2), ....., (xN , yN)} where yi = ±1 are binary
class labels, that correctly classifies the training samples and maximizes the margin.
The class of a new sample x is determined by the sign[f(x)]. All the training samples
are classified correctly if
yi(b+w
′xi) ≥ 1 for all i
The hyperplanes
b+w′x = ±1
are called the canonical hyperplanes and the distance 1/||w|| between one of the
canonical hyperplanes and separating hyperplane (3.4.1) is the margin. So, the opti-
mization problem can be rephrased as
minw||w||
subject to
yi(b+w
′xi) ≥ 1 for all i
For the non-separable case, we still maximize the margin but we allow some points on
the wrong side of the hyperplane defining the slack variables ξ = (ξ1, ξ2, ..., ξn). The
optimization problem is
min||w||+ γ
N∑
i=1
ξi
subject to
yi(b+w
′xi) ≥ 1− ξi, ξi ≥ 0 for all i
where, γ is the cost parameter that is determined by cross-validation. Using the
Karush -Kuhn-Tucker condition, the optimal values of the parameters of the hyper-
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plane are obtained as
wˆ =
∑
i∈SV
αiyixi
where, 0 < αi ≤ γ. The sum
∑
i αiyi = 0 corresponds to the support vectors xi. The
bias parameter
bˆ =
1
n0
{
∑
i∈SV
yi −
∑
i,j∈SV
αiyix
′
ix
′
j}
where n0 is the number of support vectors. Since αi = 0 for the non-support vectors
xi, the summation indices i and j are only for the support vectors. The separating
hyperplane is thus given by
f(x) = bˆ+ wˆ′x (3.4.2)
and the corresponding decision rule for a new sample x∗ is :
f(x∗) = wˆ′x∗ + bˆ
 > 0, Clasify to class 1;< 0, Classify to class 2. (3.4.3)
Using the non linear basis functions φ(xi), one can map the input space into a high
dimensional feature space. Then the samples are classified by the linear boundaries in
the feature space using the kernel K(xi,xj) = φ(xi).φ(xj) which corresponds to the
non linear boundaries in the input space. The separating hyperplane in the feature
pace is
f(x) = bˆ+
N∑
i=1
αiyiK(xi,x) (3.4.4)
Different kernels are obtained by
K(y,x) = φ′(y)φ(x)
where φ(y) and φ(x) can be any linear or non linear transformations of y and x and
must satisfy the Mercer’s Conditions [21]. But for this work, we use simple linear
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kernel,
K(y,x) = φ′(y)φ(x) = y′x+ 1
3.5 Kernel Matrix and Kernel Tricks
The matrix K = Kij = 〈Φ(xi),Φ(xj)〉 is called the kernel matrix [21]. This will
be of particularly important in the extensions of the algorithm. In the kernel based
learning methods, the input features are mapped into a high dimensional feature space
by a projection map Φ : X → Y , such that the dot product in the feature space Y is
represented by a kernel k(x, y) = 〈Φ(x),Φ(y)〉. The map Φ need not to be determined
explicitly and the computation in feature space can be done simply by taking the dot
product. Hence once the suitable kernel (which is symmetric and positive definite)
function is chosen, the user even do not need to worry about the features being used.
After this transformation, the classifier is used to classify the samples in the feature
space. This trick of computation is called the kernel trick.
3.6 High Dimensional Feature Space for Large p Small n
In the DNA microarray technology to classify the positive samples from the negative
samples, the main difficulty arises from the fact that the number of samples, n, is
small, generally less than one hundred, relative to the number of genes, p, which is
in several thousands. Golub et. al.(1999) used the gene expression data to classify
between acute myeloid leukemia (ALL) and acute lymphocytic leukemia (ALL). Since
then, disease classification using microarray data has been focus of intensive research
with the aim of providing more accurate diagnostic tools than what traditional patho-
logical method alone can provide.
The basic idea of high dimensional comes from the fact that, the training pairs
(xi, yi), i = 1, 2, ..., n are separated by maximizing the margin between the support
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vectors by the hyperplane
{x : D(x) = w.x+ b = 0}
where w =
∑n
i=1 αiyixi. In the cases when it is impossible to get a hyperplane that
classify the points in low dimension, we map those points into high dimensional space
thus making it possible to classify easily.
Let φ be a feature map that maps each point x into φ(x). Then the decision
function in the feature space is given by
D(x) = w.φ(x) + b
where w =
∑n
i=1 αiyiφ(xi). So, the decision surface is given by
D(x) =
∑
i∈S
αiyiφ(xi).φ(x) + b
According to the Hilbert-Schmidt theory, the inner product in the feature (Hilbert)
space can be represented as
φ(x).φ(y) =
n∑
i=1
arφr(x).φr(y) = K(x,y)
where , K(x,y) is a symmetric function that satisfies the Mercer’s Condition
n∑
i=1
n∑
j=1
K(x,y)hi(x)hj(y) ≥ 0
for all hi, hj, and natural numberM . This means that for any kernel function K(x,y)
satisfying the Mercer’s condition there exists a feature map g such that the inner prod-
uct in the feature space is generated by g.
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By above property, the decision surface now can be written as
D(x) =
∑
i∈S
αiyiK(xi,x) + b
where, x is a test point and xi is a support vector obtained from training set. The
decision rule is
x ∈
 Class 1, if D(x) > 0Class 2, if D(x) < 0
and undecided if x = 0.
Hence, we see that, the points are linearly separable in the feature space although
they are not linearly separable in the input space. For this we need to know the kernel
functions, instead of the actual transformation. Some of the important kernels are:
• dth Degree Polynomial Kernel, K(X,Y) = (1 + 〈X,Y〉)d
• Radial Basis Kernel, K(X,Y) = exp(− ||X−Y||2
c
)
• Neural Network Kernel, K(X,Y) = tanh(κ1〈X,Y〉+ κ2)
Note that each random variable X represents a sample. So, in the case of gene ex-
pression, the number of components of X are very large.
3.7 Nearest Shrunken Centroids Method
The purpose of discriminant analysis or classification is to assign samples to one of
the several (G) classes based on a set of measurements x = (x1, x2, ..., xp) measured
from samples. In the case of supervised learning, the classes are predetermined from
a set of samples, called training samples. These training samples are used to build a
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classifier. The classifier is then used to determine the class of a new sample. When a
sample is misclassified, then an error is said to be incurred. The cost or loss associated
with such an error is defined as
L(k, kˆ) =
 0, if k = kˆ ;1, otherwise. (3.7.5)
where k is the correct group of the sample and kˆ is the assignment made to that
sample by the classifier. If the class conditional densities, fk(x), and the class priors,
pik, of class k are known, then Bayesian optimal rule of classification to classify a new
sample x∗ is to minimize the risk
R(kˆ|x) =
G∑
k=1
L(k, kˆ) Pr(G = k|X = x) (3.7.6)
Then the classification rule is:
kˆ = argmaxk fk(x
∗)pik.
But, the problem is we do not know the class conditional densities, fk(x), of each of
the classes. So, many researchers assume that these densities are multivariate normal
with densities,
fk(x) = (2pi)
−p/2|Σk|−1/2 exp[−1
2
(x− µk)′Σ−1k (x− µk)]
Then assuming the equal variance-covariance matrix of each class, Σk = Σ, the linear
discriminant score
Dlk(x) = x
′Σ−1µk − 1
2
µ′kΣ
−1µk + log pik (3.7.7)
and assuming classwise covariance matrices unequal, the quadratic discriminant score
Dqk(x) = −
1
2
log|Σk| − 1
2
(x− µk)′Σ−1k (x− µk) + log pik (3.7.8)
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Generally, the maximum likelihood estimate are used to estimate the population mean
and population variance. Furthermore, the empirical probability is used to estimate
the class priors.
In the case of DNA microarray data, the number of covariates (genes), p, which
are in the order of several thousands, are much greater than the number of samples,
nk, generally within hundreds, in each class. So, the sample covariance matrix is
singular and this gives the unreliable estimate of covariance matrix because of high
variability. Friedman [14] introduced the regularized discriminant analysis in which
the the unequal variances were shrinked towards the common variance using the
regularization, thus increasing the performance of the RDA classifier. The microarray
problem is thus unique and challenging. Since the expression level of most of the
genes are same in two different treatment samples, those genes contribute little in
the case of classification. Thus it is important to identify the genes that actually
contribute for the classification. Assuming that those genes which have common class
means do not contribute for the classification, Tibshirani et. al. [47] proposed the
Nearest Shrunken Centroids (NSC) method. They used the shrinkage parameter, ∆,
for thresholding and declared those genes as non-contributing genes if the shrunken
centroids for gene g in class k,
x¯′gk shrinks to the overall mean x¯g
when the
|dgk| −∆ ≤ 0
where,
s2g =
1
n−G
G∑
k=1
∑
j∈Ck
(xgj − x¯gk)2, dgk = x¯gk − x¯g√
1/nk + 1/n · s2g
The non-contributing genes are removed from the data, thus reducing the dimension-
ality of the gene-matrix. The discriminant score of the NSC classifier was defined
as
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Dk(x
∗) =
p∑
g=1
(x∗g − x¯′gk)2
s2g
− 2 log pik (3.7.9)
In the classification process, the genes g which have each of the shrunken class-means
x¯′gk shrinks towards the overall class means x¯g in each class k = 1, 2, ..., G have the
same (x∗g − x¯′gk)2 values. So, the numerator of the above discriminant score (3.7.9)
can be replaced by the square of differences of only those genes g for which
x¯′gk 6= x¯g, ∀ k = 1, 2, ..., G
The optimal value of the shrinkage parameter, ∆, is chosen by the cross validation
that minimizes the cross-validation error. The idea of cross-validation is to obtain the
unbiased estimate of future prediction error associated with a particular observation
and is obtained by removing it from the model. This gives the genes that are useful
for classification.
3.8 Weighted Voting Method
Here we briefly review the methods of classification that are used by Golub et. al
[16]. To identify the genes which are truly expressed in the new samples, one can use
the weighted voting scheme(WVS) method. This uses a weighted linear combination
of the ”marker” or ”relevant” genes obtained in the training set to classify the new
sample. In this method, the correlation between the expression values of a gene g in
two classes is defined as
wg =
µg1 − µg2
σg1 + σg2
(3.8.10)
where µgi and σgi are the mean and standard deviations of gene g in the class
i, i = 1, 2. The larger the absolute value |wg| is the more important the gene g
is for prediction. The genes are ranked by their |wg|’s and top ones are selected.
These top selected genes are the marker or informative genes.
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For each informative gene g in the training sample, let µg1 and µg2 be the means
and σg1 and σg2 be the standard deviations respectively. Then the weight of gene g
is determined by
wg =
µg1 − µg2
σg1 + σg2
(3.8.11)
This measure is also called the signal-to-noise ratio. This weighting factor reflects
the correlation between the expression level of gene g and class distinction. The
parameter bg is calculated as
bg =
µg1 + µg2
2
, (3.8.12)
which is the average mean of expression levels of two classes. Hence we define the
parameters (wg, bg) for each informative gene in the training set. For a new sample
x∗ with x∗g being the normalized log expression level of the gene g, we calculate the
votes casted by each of the genes in the ”informative” set. The vote of a gene g is
vg = wg(x
∗
g − bg) =
µg1 − µg2
σg1 + σg2
[x∗g −
µg1 + µg2
2
] (3.8.13)
A positive vote indicates that the sample belongs to class 1 and negative vote
indicates it being in class -1. Then the total vote for the sample to be in class 1 is
obtained by adding V1 =
∑
gmax(vg, 0) and the total vote for sample to be in class
-1 is V2 =
∑
gmax(−vg, 0). Then the sample is assigned to that class corresponding
to the higher total vote. Generally, we take the 5% of most positive and 5% most
negative genes as the ”informative” genes in the training set. But this number is a
free parameter and depends on the user.
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3.9 Dudoit’s Multi-class Classification Method
Several proposals have been made for ranking the genes for multiclass classification.
Dudoit et al.(2002) used the ratio of between-sum-squares to within-sum-squares of
each gene for the multiclass classification. Explicitly, let there are G classes and the
number of samples be n each of dimension p. Then, the samples in each class
n = n1 + n2 + ....+ nG
Let x¯g be the mean of gene g over all classes. For each gene g, g = 1, 2, ...., p, let
x¯
(k)
g be the mean in class k, k = 1, 2, ..., G. Then the ranking of genes are done using
the ratio
ρg = |
∑G
k=1 nk(x¯
(k)
g − x¯g)2
(n−G)σ2g
|
where, σg is the pooled within class standard deviation of gene g:
σ2g =
1
(n−G)
G∑
k=1
(nk − 1)σ(k)2g
A new sample x∗ = (x∗1, x
∗
2, ......, x
∗
p) is then classified into class k, if
k = mink′ ||x′∗ − x¯(k′)||
where, ||.|| is the Euclidean norm, and x′∗ and x¯(k′) are the component vector and
mean of class k′ of only those component genes selected by the ranking procedure.
3.10 Gene Selection by Behrens-Fisher Statistic
In this section we are going to discuss briefly how we have developed the method
to chose the genes used for the classification. Suppose there are G different classes
in the population. Let nk be the number of samples in class k, (k = 1, 2, ..., G).
Let xgk = (xg1 , xg2 , ..., xgnk )
iid∼ N(µgk, σ2gk) be the expression level (possibly log
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transformed) of the gene g in class k. For k=1,2,....,G, the density of xgk can be
written as
f(xgk) =
1
(σgk)nk(2pi)
nk
2
exp
[
− 1
2σ2gk
{nk − 1)s2gk + nk(x¯gk − µgk)2}
]
(3.10.14)
where, x¯gk and s
2
gk are sample mean and sample variance of gene g in class k respec-
tively. Assuming the independency of location parameter µgk and scale parameter
σ2gk, the joint prior for µgk and σ
2
gk can be written as
p(µgk, σ
2
gk) = p(µgk)p(σ
2
gk) (3.10.15)
Assume that the priors for µg1 and µg2 are flat priors and the priors for σ
2
g1 and
σ2g2 are scaled inverse χ
2 distributions, i.e. p(σ2g1) = I(σ
2
g1; ν0, σ
2
0) and p(σ
2
g2) =
I(σ2g2; η0, τ
2
0 ), where, α = (ν0, η0, σ
2
0, τ
2
0 ) is the hyper-parameters that should be esti-
mated from the data.
Let ∆µg = µg2 − µg1. Then the statistic, called the BF -statistic
B =
∆µg − (x¯g2 − x¯g1)
(
σ2g1
n1
+
σ2g2
n2
)
1
2
(3.10.16)
= Bx2cosθ −Bx1sinθ
where,
tanθ =
σg1/
√
n1
σg2/
√
n2
, 0 ≤ θ ≤ pi
2
Bx1 =
(µg1−x¯g1)
σg1/
√
n1
Bx2 =
(µg2−x¯g2)
σg2/
√
n2
and, Bx1 and Bx2 are independently distributed as t- statistics with vn1 and vn2 degrees
of freedom respectively. Hence, the statistic B is distributed as the Behrens- Fisher
distribution with
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vn1 = n1 + ν0 − 1, and vn2 = n2 + η0 − 1
degrees of freedom [42]. That is,
B ∼ BF (vn1 , vn2 , θ)
with pdf
f(β|µg1, µg2, σ2g1, σ2g2) = k
∫ ∞
−∞
[
1+
(αcosθ − βsinθ)2
vn1
]− vn1+1
2
[
1+
(αsinθ + βcosθ)2
vn2
]− vn2+1
2
dα
where,
α = Bx2sinθ +Bx1cosθ, β = Bx2cosθ −Bx1sinθ
This can be further approximated by scaled t-statistic [31]:
B
a
∼ t(b) (3.10.17)
where,
f1 =
(
vn1
vn2−2
)
cos2θ +
(
vn1
vn1−2
)
sin2θ
f2 =
v2n2
(vn2−2)2(vn2−4)cos
4θ +
v2n1
(vn1−2)2(vn1−4)sin
4θ
a2 = (b−2)
b
f1
b = 4 +
f21
f2
cos2θ =
σ2g2
n2(
σ2g2
n2
+
σ2g1
n1
) , sin2θ = 1− cos2θ.
That is, B has approximately t-distribution with b degrees of freedom (b ≥ 1) and
scale parameter a. This statistic B can also be denoted as B ∼ t(0, a2, b) and is valid
only for vn1, vn2 ≥ 5 .
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3.11 Choosing the number of genes required for classification
For this work we select those genes that are uniformly expressed in each of the classes.
Since leave-one-out cross validation (LOOCV) error is almost unbiased estimate of
generalization error [49], we use the leave-one-out cross validation on the training
samples. The genes that are common in each of the cross validated training samples
are the preliminary set of genes that have the power to discriminate between different
classes. From this preliminary gene set, only those genes are selected that do not
further decrease the cross validation error. This final set is the optimal set that is
useful for the classification. Since the genes chosen by the t-test are the marker genes
for the two different conditions, these can be used to classify samples into any one of
the two classes. The genes selected by BF method may not be appropriate for the
multi-class classification. To fit with the multi-class classification, we want to choose
the marker genes that are useful. For this, we can use the one-versus-all method. In
this method, we take one of the class as from normal (condition 1) and combine the
rest of classes and take that combined classes as from diseased (condition 2). Then we
use the leave-one out method in the training set to choose the genes that are useful
for the classification. We simply leave one of the training sample and find the genes
that are differentially expressed by the BF method in the rest of training samples that
contains samples from both conditions. We repeat this procedure for all the samples
in the training set. Then the differentially expressed genes that are common in each
of the leave-one-out training set is taken as the marker genes, which we choose as
the genes useful for classification. We repeat the same procedure for the rest of the
classes ( leaving the classes that were used) and get the differentially expressed genes.
Finally, the informative genes are those common genes that is found expressed, thus
uniformly expressed, in all the classes and leave one out training sets. Using this gene
set, we classify one sample with the rest. In the above example, we classify the ALL
sample with the rest. Then, this is repeated for all remaining classes. This method is
the one-versus-all method.
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3.12 Simulation and Results
To evaluate how well the genes selected by the Behrens -Fisher Statistic mentioned
above performs the classification tasks, we have simulated four classes each with 10,000
genes as in the following:
1. Out of 10,000 genes, simulate 98,00 genes from a normal distribution with mean
µ ∼ U [0, 1] and variance σ2 ∼ Inv − χ2(df = 20, scale = 2).
2. Without loss of generality, simulate first 100 genes from normal distribution with
mean µ ∼ U [5, 10] + 1
2
and variance σ2 ∼ Inv − χ2(df = 20, scale = 4) in the
control condition and mean µ ∼ U [5, 10] − 1
2
and variance σ2 ∼ Inv − χ2(df =
18, scale = 6) in the control condition.
3. simulate another 100 genes from normal distribution with mean µ ∼ U [5, 10]− 1
2
and variance σ2 ∼ Inv − χ2(df = 18, scale = 6) in the control condition and
mean µ ∼ U [5, 10] + 1
2
and variance σ2 ∼ Inv − χ2(df = 18, scale = 4) in the
control condition.
4. Repeat steps 1 to 3 to simulate another two classes, but replace the scales by 3
by and 6 respectively.
5. The combined simulated data will have 10,000 genes and 4 classes.
In the 4 classes, we have 15−10, 13−5, 30−12, and 23−12 training and test samples
respectively. The BF statistic was used to select the genes. It selected most of the
genes that were marked as differentially expressed in the simulation. We used these
selected genes in the SVM classifier and in the Weighted Voting (WV) methods.
The accuracy rate (AR) of a classifier is defined as
AR =
No. of Samples Accurately Classified by the Classifier
Total no. of Samples
(3.12.18)
The support vector machines misclassified 3.1 samples on average, whereas the
WV method misclassified 0.037 of the samples incorrectly on average. The multiclass
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algorithm of Dudoit made the most mistakes in the test samples although it classified
the samples correctly in the training set. On average, it misclassified 0.15 of the test
samples incorrectly. Finally, the RDA performed more accurately. It misclassified 1
samples out of 39 test samples when all 10,00 genes were used. For this, α = 0.11
and ∆ = 2.33. But, when we use the genes selected by the proposed Behrens-Fisher
method, the following Table 3.1 was obtained.
Method no. of Genes used No. of Classes Accuracy
SVM 203 4 .92
WV 203 4 .97
Dudoit 203 4 .84
SCRDA 203 4 .84
Table 3.1: Accuracy Rate for the Simulated Test data
3.13 Datasets Pre-processing and Filtering
All the data sets used in this paper are oligonucleotide microarray data and was pre-
processed as in Dudoit et. al.[10] (2002). The threshold was set with floor of 100
units and ceiling of 16,000 units. A ceiling of 16,000 units was chosen because it is
at this level that we observe the flourescence saturation of the scanner; values above
this can’t be reliable measure. Similarly a floor of 100 units was chosen to minimize
the noise and maximise the interpretation of marker genes due to the correlation
of genes. We have filtered out (excluded) those low quality genes that have ratio
(max/min) < 5 and (max−min) < 500 across all of the samples. To make the data
somewhat symmetrical, base-10 logarithm has been used for the transformation.
3.14 MLL Leukemia Data
MLL Leukemia data is Affymetrix oligonucleotide data and consists of 72 samples
and 12,582 genes. There are 3 different classes - ALL, MLL, and AML. ALL has 20
training sample and 4 testing samples, MLL has 17 training samples and 3 test sam-
ples and AML has 20 training samples and 8 testing samples. After the preprocessing
and filtering the low quality data, we are left with 8,681 genes.
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Figure 3.1: Histogram of Pre-processed AML Data
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Figure 3.2: Histogram of ALL,MLL and AML Training and Testing Data after Pre-
processing
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Method Training Errors Test Errors Average Error No. of
ALL MLL AML ALL MLL AML Train Test Genes
Dudoit 0 1 1 0 0 0 2 0 23
Wt. Vote 0 1 1 0 0 0 2 0 17
SVM 0 0 0 0 0 0 0 0 17
NSC 0 4 0 0 0 0 4 0 12
Table 3.2: Comparison of Classification Performance on MLL Leukemia Data.
Table 3.2 shows the comparison and performance of different methods for this
data. The nearest shrunken centroid (NSC) method chooses only 12 genes but the
performance of the model in the testing samples are not as good as in the other
method. It makes four errors when classifying the training samples. The genes chosen
by the Beherens-Fisher statistic have more discriminating power, as seen by these
genes used in weighted voting, Dudoit and Support Vector Machines methods. In
all methods, misclassification occurs only in the training samples. The SVM method
seems to be one of the perfect classifiers. Since the SVM has solid mathematical
derivation that is derived by optimizing the margin between two classes, one can
expect that it is one of the best classifiers. We see from the classification performance
of Golub data that it makes no error in training and testing samples.
3.15 Golub Leukemia Data
Golub Leukemia data consists of 7,129 genes and 72 samples. These samples are from
two classes: Acute Lymphoid Leukemia (ALL) and Acute Myeloid Leukemia (AML).
We have chosen 38 training samples: 27 ALL and 11 AML, and 34 testing samples
: 20 ALL and 14 AML as in Golub et. al.[16]. First of all, the classification of the
samples are done using all the genes.
Here from the Table 3.3, we see that, taking all the genes into consideration, there
is one AML sample in that was misclassified as ALL sample by the SVM method.
Similarly, the Weighted Vote and Multiclass methods misclassified two AML samples-
the one is the same misclassified by the SVM method, into ALL samples.
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Figure 3.3: Cross-Validation Error of Nearest Shrunken Centroid Method for MLL data
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Method Training Errors Test Errors Total Errors
ALL AML ALL AML
W. Vote 0 0 0 1 1
SVM 0 0 0 2 2
Multi-class 0 0 0 2 2
Table 3.3: Comparison Classification of Golub Data using all the genes
Next we use only those genes selected by the Behrens Fisher method. We have
used the selected genes in three classification methods: Support Vector Machines
method, Weighted Vote Method and Dudoit Multiclass Method. Using the training
samples (27 ALL and 11 AML), we got 639 genes as differentially expressed. We used
these 639 genes for the classification. The result was shown below:
Method Training Errors Test Errors Total Errors
ALL AML ALL AML
W. Vote 0 0 0 1 1
SVM 0 0 0 1 1
Multi-class 0 0 1 1 2
Table 3.4: Comparison Classification of Golub Data using BF selected genes
In the Table 3.4, we have seen that the genes selected by the BF method actually
are useful for the classification. There is no training errors by each classification meth-
ods, all of the 38 samples are classified correctly. To see whether the classifier build
by using the selected genes actually work for the unseen samples, it has been found
that the the SVM and Weighted Vote misclassifies 1 samples each out of 34 samples
and Multiclass method misclassifies two samples. More specifically, SVM method
misclassifies one AML sample as ALL. This is the same sample as misclassified by the
SVM and multiclass method. The Weighted Vote misclassifies one AML sample as
ALL. Multiclass method misclassifies 2 test samples: one ALL sample as AML and
one AML sample as ALL. This could be because the BF distribution selects the genes
for classifying 2 samples and the multiclass method is generally for the multi-classes.
So, from the comparison of the above two tables, we see that, even though we use
all the genes for the classifiers, the classification performance is not improved. In fact,
the performance was improved if we take the genes selected by the BF method.
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Next, we have selected 33 genes by the BF method using LOOCV error. These
genes were used for the classification of ALL and AML samples. The classification
error are shown in Figure 3.4. The genes selected by BF method seems optimal set
in the sense that it makes very few error in classifying the samples. It makes no error
while using the SVM method, whereas it makes 1 error out of 38 training samples
and 1 error out of 34 testing samples. As the number of genes increased, the error
does not decrease when we select 80 genes. By taking 8 genes, it has been found that
3 errors were made in the training samples and 2 errors were made on the testing
sample.
Method Training Errors Test Errors No.of Genes
ALL AML ALL AML
W. Vote 1 0 1 0 33
SVM 0 0 0 0 33
NSC 0 0 1 0 18
Table 3.5: Comparison of Classification Performance on Golub Data.
3.16 Subtypes of Pediatric Acute Lymphoblastic Leukemia
This data consists of 12,625 genes and 327 samples. There are 7 classes and the
samples are separated as training and test samples. For the comparison purposes, we
have selected the same 215 training and 112 test samples as in Pomeroy et. al. (2001)
[33]. These are : BCR (9 train, 6 test), E2A (18 train, 9 test), HYP (42 train, 22
test), MLL (14 train, 6 test), T.ALL (28 train, 15 test), TEL.AML (52 train, 27 test),
Others (52 train, 27 test). After applying the pre-processing and filtering steps, ther
are 12,061 genes. For the sake of convenience, we call this data as ALL-7 data.
In this 7 classes case, the genes selected by the BF method has shown the promis-
ing result over the nearest shrunken centroid (NSC) method and shrunken centroid
regularized discriminant analysis (SCRDA) method of Guo et. al. (2007). In the NSC
and SCRDA methods, the overall mean of each classes are shrunk by a shrinking fac-
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Method Classes Total No.of
bcr e2a hyp mll t.all tel.aml other Error Genes
Tr W. Vote 0 0 0 0 0 0 2 2 370
a Dudoit 2 0 1 0 0 1 16 20 150
i NSC 9 0 7 8 0 0 2 26 185
n SCRDA 0 0 2 0 0 0 12 14 543
T W. Vote 0 0 3 0 0 0 4 7 370
e Dudoit 1 0 1 0 0 1 3 6 150
s NSC 6 0 21 6 0 0 6 39 185
t SCRDA 1 0 2 0 0 0 10 13 543
Table 3.6: Comparison of Classification Performance on ALL-7 Data.
tor. We have used the genes selected by the proposed BF statistic for the Weighted
Voting method. For the Dudoit method, we have used the 150 genes selected by
the BF statistic. The classification performed by both weighted vote and Dudoit
method are better than the rest two methods. The overall error for the weighted
vote method in the training samples is .0093 whereas it is 0.1209 and 0.0651 in NSC
and SCRDA methods respectively. Similarly, the overall test errors in the weighted
voting method is 0.0625, and that is 0.3482 and 0.1160 in NSC and SCRDA methods
respectively. Another important fact to note is that the number of genes selected for
the classification by BF method is also comparable to both of these methods.
Class MLL Data Golub Data
Predicted Predicted
True ALL AML MLL ALL AML
ALL 20 0 0 20 0
AML 0 19 1 1 13
MLL 0 1 16
Table 3.7: Confusion matrix for the MLL-3 training data by Dudoit method, and Golub
Test Data by NSC Method.
The confusion matrix, as described in the Section 5.2 of Chapter 5, for the different
methods are shown in Table 3.7 and in Table 3.8. It is the matrix of number of sam-
ples classified by the method, and shows explicitly how many samples are misclassified
and in which class they were assigned by the classifier. For the ideal classifier, the
matrix has all the non-diagonal elements are zero. The sum of the all the elements of
a confusion matrix is the number of samples used for classification.
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In the Table 3.7, we see that the NSC method misclassifies 2 samples out of 57
samples in the MLL data with 3 classes. There is no error in the ALL samples. But,
one AML sample was misclassified as MLL sample and one MLL sample was misclas-
sified as AML sample. On the right side of the table we have classified the Golub
data using the NSC method. There we see that one ALL sample was misclassified as
AML sample.
Class Predicted
True BCR E2A HY P MLL T.ALL TEL.AML Others
BCR 5 0 0 0 0 0 1
E2A 0 9 0 0 0 0 0
HY P 0 0 20 0 0 0 2
MLL 0 0 0 6 0 0 0
T.ALL 0 0 0 0 15 0 0
TEL.AML 0 0 0 0 0 27 0
Others 4 0 3 0 0 3 17
Table 3.8: Confusion matrix for the ALL-7 test data by SCRDA method.
Similarly from Table 3.8, we see that while the SCRDA method was used for
the classification, 4 BCR samples were misclassified as others, 3 HYP samples were
misclassified as others, 3 TEL.AML samples were misclassified as others and one
sample which was on the others class was misclassified as BCR.
3.17 Conclusion
In this chapter we have used the genes selected by the proposed Beherens-Fisher
distribution for the classification of samples. For the classification, we have used
the Weighted Vote, Multiclass, Neares Shrunken Centroid and Shrunken Centroid
Regularized Discriminant Analysis for classifying binary and multiclass classification
as seen on Sections 3.14, 3.15, 3.16 . We have also shown the classification performance
of classifiers using the confusion matrix in Section 3.16.
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Chapter 4
Selection of Differentially Expressed Genes in Correlated Statistics
4.1 Summary
When testing the large number of hypotheses in the microarray data simultaneously,
one need to assess the evidence against the global null hypothesis that none of the hy-
potheses are false [11]. Such evidence is typically based on the test statistics obtained
from the data using, for example, t-test in the control and experimental samples. For
the large number of hypotheses to be tested, the reliability of the outcome depends
on the correlation between the corresponding test statistics as seen in Section 4.3.
This can severely affect the accuracy of the decision in the applications of popular
multiple testing methods such as false discovery rate as seen in Section 4.4 which
does not require independence of the test statistics. In this chapter, the effect of the
correlated test statistics in the spread of the histogram of standardized test statistics
are discussed and the effect of the correlation is analyzed using the real and simulated
data.
4.2 Introduction
Let us consider that we have the gene expression xij microarrays from two condi-
tions: control (m samples) and experimental (n samples). In each sample there are
p genes. The test statistics from these two microarray experiment can be obtained
using the Behrens-Fisher (BF) Statistics as described in Chapter 3. For each gene i,
the corresponding BF statistic is denoted by ti. For easier analysis, these statistics
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are converted into the standard normal score
zi = Φ
−1(G0(ti)) (4.2.1)
where, G0 is a believed null cumulative distribution function (cdf) of the ti values
and Φ is the standard normal cdf. Since microarray experiments usually presupposes
that most of the genes are not differentially expressed between two conditions, we
expect that the N(0, 1) density curve fits the center of the histogram of zi values. If
there is no correlation among the test statistics, ti, then after the transformation we
expect that the zi values follow standard normal density. If the correlation among
ti is present, then it has effect on the widening or narrowing the standard normal
density curve of the zi values. This has serious effect on the tail counts, which are the
differentially expressed genes. Because this is the data driven method, it has no other
assumption except that the data are independent and identically distributed and the
test statistics are independent.
4.3 Effects of Correlations
To know the effecte os correlation, we discretise the transformed test statistics, zi by
partitioning into bins or intervals. Generally the number of intervals, K, is chosen by
K = 1 + 3.3log(n). Let yk = no. of zi in the kth bin, k = 1, 2, ..., K. This makes the
partition of the sample space, Z, obtained by the z-scores into K bins: Z1, Z2, ....., ZK
such that Z = Z1 ∪ Z2 ∪ ... ∪ ZK and the center point of the kth bin, z[k]. Defining
pik(i) = Pr(zi ∈ Zk), pik. =
∑p
i=1 pik(i)
p
(4.3.2)
and
γkl(i, j) = Pr(zi ∈ Zk and zj ∈ Zl), γkl. =
∑
i6=j γkl(i, j)
p(p− 1) (4.3.3)
all the pik(i) values are determined by the standard normal density, φ(z), around the
point z[k]. The following result was proved by Efron [11].
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Lemma: Let y = (y1, y2, ..., yK). Then
Cov(y) = C0 + C1 (4.3.4)
where, C0 is the multinomial covariance matrix that would apply if the z-values were
independent,
C0 = diag(ν)− νν ′/p = p[diag(pi.)− pi.pi.′] (4.3.5)
and
C1 =
(
1− 1
p
)
diag(ν) δ diag(ν) with δkl = γkl./pik.pil.− 1 (4.3.6)
where, ”diag” represents p × p diagonal matrix δ whose elements are δkl and pi =
(pi1., pi2., ..., piK)
′.
Proof :
When k 6= l, then
E(ykyl) =
∑
i6=j
γkl(i, j)
= p(p− 1)γkl. (4.3.7)
and,
Cov(yk, yl) = E(ykyl)− E(yk)E(yl)
= p(p− 1)γkl. − p2pik.pil. (4.3.8)
and,
V ar(yk) = Cov(yk, yk)
= p(pik.− pik.2) + p(p− 1)(γkk. − pik.2) (4.3.9)
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where, γkk(i, j) is given by
γkl(i, j) =
∆2
2pi
√
1− ρ2ij
exp
[
− 1
2
z[k]2 − 2ρijz[k]z[l] + z[l]2
1− ρ2ij
]
(4.3.10)
From the above lemma, if zi and zj are independent, then γkl(i, j) = pik(i)pil(j).
This means all the elements of the δ in (4.3.6) are zero, thus C1 = 0. So, Cov(y) = C0
if the statistics are not correlated. Furthermore, the amount of correlation between
the t-scores determines the size of δ and increases the Cov(y) above C0. The elements
δkl of δ can be estimated by
δˆkl =
∫ 1
−1
[ 1√
1− ρ2 exp
( ρ
2(1− ρ2){2z[k]z[l]− ρ(z[k]
2+ z[l]2)}
)
− 1
]
g(ρ)dρ (4.3.11)
where, ρ is the correlation matrix and g(ρ) is the empirical density of p(p − 1)/2
correlations, ρij, of genes.
Let us define
Y0 = No. of {zi ∈ [−a, a]} and Y1 = No. of {zi ≥ b} (4.3.12)
where, a and b are suitable positive numbers (cutoffs) which covers the central and
tail part of the density of zi. We will analyze the effect of correlations of zi on the
sd(Y0) and sd(Y1); and on the Cor(Y0, Y1) in the application section.
We will use the above lemma to find the sd(Y0) and sd(Y1), Cor(Y0, Y1).
4.4 Application
The golub data described in the chapter 3 was used to test the correlation of genes
and its effects on testing simultaneous multiple hypotheses. Because of thousands of
hypotheses are tested simultaneously, there is a greater chance of correlation among
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the test statistics. To know whether the statistics are correlated or not, the first visual
method is to transform the test statistics using the equation (4.2.1) and see whether
the transformed standard z - scores are actually fit the standard normal curve. In
the golub data, the histogram was produced for the transformed standard z - values.
The Behrens Fisher (BF) test statistics was obtained by the proposed method Sec-
tion 3.10 of Chapter 3. The BF test statistics were transformed into z-scores. The
distribution of the Behrens Fisher statistic was found to fit the Cauchy distribution
with mean = −0.111142 and standard deviation = 1.733 , Kolmogorov’s Goodness of
Fit test = 0.0533, with rank 1. This means that Cauchy distribution fitted best to
the BF test statistics. The cumulative distribution function G in equation (4.2.1) is
the cumulative distribution function of Cauchy distribution with mean = −0.111142
and standard deviation = 1.733. The table for the goodness-of-fit test was given in
the Table 4.1.
Distribution Kolmogorov-Smirnov Anderson-Darling Chi-Square
Statistic Rank Statistic Rank Statistic Rank
Cauchy 0.05333 1 12.205 1 117.45 3
Log-logistic 0.05534 2 12.285 2 81.852 1
Johnson (SU) 0.06687 3 14.46 3 98.901 2
Table 4.1: Goodness-of-Fit test of the test-statistics obtained by the BF method for the
Golub Data
The density of the correlations is given in the Figure 4.3. It is approximately
normal, N(0, 0.262).
Let us take, in particular, a = 0.75 and b = 3.0 in equation (4.3.12) as suggested
by Efron, 2007. Since out of all the genes the probability to lie in the interval of
[−0.75, 0.75] can be considered as success, we model that Y0 is approximated by the
binomial distribution with n = No. of genes, and probability of Y0 lying in the
[−0.75, 0.75] = Φ(0.75) − Φ(−0.75). Similarly, Y1 is approximated by the binomial
with probability of Y1 lying in [3,∞] = 1 − Φ(3). The covariance between the genes
is obtained by using the Lemma 1,
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Figure 4.1: Histogram and the fitted Cauchy density curve for the BF test statistics
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Histogram of Transformed Test Statistics
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Figure 4.2: Histogram of transformed test-statistics
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Figure 4.3: Density, g(ρ), of correlations between the genes
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Cov(Y0, Y1) = E(Y0Y1)− E(Y0)E(Y1)
= p(p− 1)γkl. − p2pik.pil. (4.4.13)
where, γkl. is given by (4.3.3) and pik. and pil. are given by (4.3.2) with suitable
modification to cover the intervals. In particular, if zi and zj are independent, then
γkl. = pik.pil. = [Φ(0.75) − Φ(−0.75)][1 − Φ(3)]. There are p = 1761 genes remaining
after preprocessing, normalization and transforming into normality.
sd(Y0) =
√
p[Φ(0.75)− Φ(−0.75)][1− (Φ(0.75)− Φ(−0.75))]
=
√
1761(0.5467453)(1− 0.5467453)
= 20.89 (4.4.14)
sd(Y1) =
√
p[1− Φ(3)]Φ(3)
=
√
1761(1− 0.9986501)(0.9986501)
= 1.54 (4.4.15)
Cor(Y0, Y1) =
Cov(Y0, Y1)
sd(Y0).sd(Y1)
=
p(p− 1)[Φ(0.75)− Φ(−0.75)][1− Φ(3)]− p2[Φ(0.75)− Φ(−0.75)][1− Φ(3)]
(20.89)(1.54)
=
1761(1760)(0.5467453)(1− 0.9986501)− (1761)2(0.5467453)(1− 0.9986501)
(20.89)(1.54)
=
−1.2997
32.1706
= −0.04 (4.4.16)
Now, let the transformed statistics zi and zj are correlated. Then the average of all
correlations between the genes is 0 as seen from the Figure 4.3. Using the results of
above Lemma for the variable Y0, we get
97
Sd(Y0) =
√
p[Φ(0.75)− Φ(−0.75)][1− (Φ(0.75)− Φ(−0.75))] + p(p− 1)
√
[(Φ(0.75)− Φ(−0.75))− (γ0.75,0.75 − Φ(0.75))2]√
1761(0.5467453)(1− 0.5467453) + 1761(1760)[0.314062− 0.54674532] = 217.56
(4.4.17)
Similarly, the Sd(Y1) and Cor(Y0, Y1) are obtained as
Sd(Y1) =
√
p(Φ(3))[1− Φ(3)] + p(p− 1)(γ3,3 − Φ(3)2)
=
√
1761(0.9986501)(1− 0.9986501) + 1761(1760)(0.997451− 0.99865012)
= 21.54 (4.4.18)
Cor(Y0, Y1) =
Cov(Y0, Y1)
sd(Y0).sd(Y1)
=
p(p− 1)× 0− 17612[Φ(0.75)− Φ(−0.75)][1− Φ(3)]
(217.56)(21.54)
=
−2288.787
(217.56)(21.54)
= −0.488 (4.4.19)
4.5 Computation of Effect of Correlations
The following Table 4.2 summarizes the effect of correlation on the spread of the
histogram. Because of the correlation among the test statistics in multiple testing
the standard error multiplies by the several fold. We can see that the standard de-
viations of tail counts and middle portion count of the transformed test statistics
are multiplied by the several folds when we consider the correlation among the test
statistics as compared to when they are independent. Furthermore, the correlation co-
efficient, which is almost negligible when the test statistics are assumed independent,
has tended toward large negative value.
98
Independent Correlated
sd(Y0) 20.89 217.56
sd(Y1) 1.54 21.54
cor(Y0, Y1) -0.04 -0.488
Table 4.2: Effect of Correlation on the standard deviations of the middle and tail count of
the transformed test statistics
4.6 Conditional and Unconditional p - values
One of the ways [37] to alleviate the problem arising from the correlated test statistics
is to condition the central portion Y0 of the normalized test statistics, zi. If X =
maxi |zi|, i = 1, 2, ..., p, and the p statistics, zi, were independent, then the overall
p-value associated with the observed value X = x is given by
px = 1− [1− 2Φ(−x)]p .= 2pΦ(−x) (4.6.20)
where, p is the number of hypotheses to be tested. Because the shape of the histogram
of z values varies with the correlated test statistics than it does for the independent
test statistics, the p-value to test the null hypotheses should be smaller than the ac-
tual p-value obtained from the assumption of independent test statistics. The larger
variation among the histograms of correlated test statistics can cause misleading tail
counts and thus more genes are declared to be differentially expressed than actual
number of differentially expressed genes.
The conditional p-value is estimated by permuting the samples and calculating the
number of zi’s that lie inside a small interval (C − δ, C + δ) around C, where,
C =
#(zi : |zi| < 1)
p
(4.6.21)
In particular, we find the values of X = maxi |zi|, i = 1, 2, ..., p , say x, and C
from the original non-permuted samples. Permutation of samples is repeated many
times, say B. In each permutation b, the following are calculated: (1) the proportion
of genes, Cb, lying within (C − 0.05, C + 0.05) (2) Yb = 1 if xb > x and Yb = 0
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otherwise (3) coefficients αˆ and βˆ by fitting the logistic regression, log
(
P (Yb=1|Cb)
1−P (Yb=1|Cb)
)
=
exp(α+βCb). Finally, the estimate of conditioned p-value at the point C = c is given
by
pˆx(c) =
exp(αˆ + βˆc)
1 + exp(αˆ+ βˆc)
(4.6.22)
Similarly, the unconditional p-value, Px, is estimated as the proportion of all per-
mutations whose maximum test statistic exceeds the observed value x. Those genes
with p-value less than or equal to the adjusted p- value are taken as the differentially
expressed genes. In the Golub data, the permutation was repeated 5000 times to
calculate conditional p-value and unconditional p-value.
C = #(zi:|zi|<1)p = 0.28393
X = maxi |zi| = 2.078
E(C) = Φ(1)− Φ(−1) = 0.6827
V ar(C) = 0.00016
Unconditional p-value, Pˆx = 0.0286 [for 5000 permutations]
Conditional p-value, pˆx(c) = 0.0577 [for 5000 permutations]
Table 4.3: Effect of correlation on p -value on test statistics in Golub data
In the Table 4.3, we see that the X = maxi |zi| = 2.078 and C = 0.28393. Since
this value of C is smaller than the E(C) = 0.6827, the histogram of test statistics
is more wider than expected under the assumption of independence. The magnitude
of difference between these two conditional and unconditional p-value is |0.0286 −
0.0577| = 0.0291. Hence the p -values should be adjusted accordingly. Table 4.2 gives
some insight about the actual effect of correlations. The correlation among the genes
increases the standard deviation of Y0 by almost 10-fold, the standard deviation of Y1
by almost 14-fold, and the correlation by almost 12-fold toward the negative side.
4.7 Dispersion Parameter
The central peak of the histogram depends on the dispersion parameter A. If there
is no correlation between the test statistics, then A = 0. Positive value of A widens
the central peak whereas the negative value of A narrows the central peak. This is
reflected in the Figure 4.2. Taking x0 = 2.0 (which is almost 95% confidence interval
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by the normal theory) for the cut points of the test statistics, zi, one can obtain the
dispersion parameter A as in Efron [11] which conditions the FDR on A
FDR{x|A} = E{Y (x)|A}
T (x)
. (4.7.23)
Let us define
Y0 = number of zi ∈ [−x0, x0]
P0 = 2Φ(x0)− 1
Q0 = 2
√
2φ(x0)
Pˆ0 =
Y0
p
Aˆ =
P0 − Pˆ0
Q0
(4.7.24)
where, φ is the standard normal density function, and Φ is the standard normal cu-
mulative distribution function. For the Golub data with x0 = 2, we got the following:
Y0 = 1760
P0 = 0.9545
Q0 = 0.1527
Pˆ0 =
1261
1761
= 0.716
Aˆ = 1.561
In the Figure 4.2, the cut-off value of the z statistics correspond to the Behrens-
Fisher test statistics of α = 0.05 is given by 1.24. But because of the correlation
we need to adjust the value of z, so that the correlation among the test statistics
affect the inference as little as possible. Hence, taking the conditional p-value for
the transformed zi data, the cut-off values is 1.574. Hence, we declare those genes
as differentially expressed if the |zi| < 1.574. Using this as a cut-off value, we got
32 + 64 = 96 genes as differentially expressed. Hence, there are 96 genes that are
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found to be differentially expressed after taking into account of correlation among the
test statistics.
4.8 Conclusion
In this chapter we have studied the effect of correlation on the test statistics in Section
4.5. The effect of the correlated test statistics on the selection of genes have been
studied in Section 4.7. The cut-off of z-values should be adjusted so that the effect
of correlation is as small as possible. Furthermore, a method of how to find the
cutoff using the p-value obtained by conditioning the central part of the histogram to
account for the correlation has been studied in Section 4.6 . So, the possible interval
in which we accept the null hypotheses have been determined.
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Chapter 5
Performance of a Classifier taking into account of Correlated Genes
Summary: In this chapter, we introduce the correlation between the genes and study
its effect on the performance of different classifiers. Furthermore, we have introduced
how to set up the cut-off value while filtering the highly correlated genes. We have used
McNemar’s test to test the hypothesis of whether the two classifiers performance are
same.The assumptions for this test is the data are independent and they are classified
into two classes. Since the confusion matrix is generally used for the performance of
classifiers in the multiclass classification task, we have calculated confusion matrices
for different data and we have used these matrices for measuring the performance of
classifiers.
5.1 Performance of Classifiers
Despite one’s best efforts to remove the misclassification classifier does not perform
well, particularly with the new data. Understanding the potential causes of poor per-
formance can be useful guide to possible alterations that might improve performance.
Classifiers fail to make sufficiently accurate predictions in a number of circumstances.
1. The form of classifier is too complex and over-fits the data. This tends to
arise when the ratio of parameter to cases exceeds some desirable limit and the
classifier begins to fit the random noise in the training data. This will lead
to poor generalization. This is why simple models often outperform complex
models on novel data.
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2. The form of classifier is too simple or has an inappropriate structure. For ex-
ample, classes may not be linearly separable or important predictors have been
excluded. This will reduce accuracy.
3. If some of the training class labels are incorrect or ’fuzzy’ there will be problems.
Most classifiers assume that class membership in the training data is known
without error. Obviously if class definitions are ambiguous, it becomes more
difficult to apply a classification procedure, and any measure of accuracy is
likely to be compromised. More importantly, mislabeled cases can influence the
structure of the classifier, leading to bias or classifier degradation. For example,
a misclassified sample may be an outlier for some predictors, but its influence
will depend on the classifier. In discriminant analysis outliers may have large
effects because of their contribution to the covariance matrix.
4. Training samples may be unrepresentative. If they are, this leads to bias and
poor performance when the classifier is applied to new samples. Careful sampling
designs should avoid this problem but such bias may be unavoidable if there is
significant unrecognised regional and temporal variability.
5. Unequal class-sizes in training and test sample also may affect the classifier’s
performance.
5.2 McNemar’s Test and Confusion Matrix
This test is generally used to determine the significance of the two methods used for
the classification. So, it is used to access the classification performance of binary
classifiers. The entries in the Table 5.1 are numbers of misclassifications. In eij, the
subscript i represents classification by method I and subscript j represents the clas-
sification by method II. Furthermore, if the subscript is 0 then correct classification,
and if it is 1 then misclassification. Under the null hypothesis that the classifiers have
same error rates, the McNemar’s test statistic, M , is given by
M =
(|e01 − e10| − 1)2
e01 + e10
∼ χ2(1) (5.2.1)
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Classifier II
Classi- e00 e01
fier I e10 e11
Table 5.1: Contingency table for misclassification
When we classify the samples in two or more than two classes, there are some error
since no classifier is perfect. The classification performance of the classifier can be
easily seen from the confusion matrix, see Table 5.2. The confusion matrix is a matrix
in which the entries are the no. of samples misclassified. The columns represent the
true class of the samples and the rows represent the predicted class. Thus it is easy to
see that how many samples are misclassified and the assignment of the misclassified
samples in the classes.
Actual
1 2
Pred- 1 a b
icted 2 c d
Table 5.2: Confusion Matrix for misclassification
5.3 Filtering the Highly Correlated Genes
For a subset S of genes obtained from the Behrens-Fisher Distribution, the discrim-
ination ability and the correlation of genes can be found by computing the score of
each of the genes as in Liu et al. [27]. Let g be any gene in S. If there are 2-classes,
G = 2 with class labels k = 1 and 2, we determine the score of each of the genes. Let
µgk be the mean and σ
g
k be the standard deviation of gene g in class k. the discriminant
ability of the gene g is described by [27]
Dg =
|µ1g − µ2g|
σ1g + σ
2
g
(5.3.2)
From (5.3.2), it can be seen that the larger the Dg, the further the classes are sepa-
rated. Therefore, the better the discriminant ability the gene g has. The correlation
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between the genes g and h can be calculated by
rg,h =
2∏
k=1
Cov[Sk(g), Sk(h)]√
V ar(Sk(g)).V ar(Sk(h))
(5.3.3)
where, Sk(g) = (xg1, xg2, ..., xgk) is the vector of components of gene g in the class k
only. Based on rg,h, the correlation coefficient between a single gene g and the subset
S is determined as
rg,S = max
h∈S
|rg,h|. (5.3.4)
A high value of rg,S indicates that g is highly correlated with certain gene in S, and
therefore it carries the redundant information.
Finally, it is desirable to select the genes that can individually separate the classes
well and has small correlation with the genes in the subset S. The final score assigned
to each of the gene g is defined as
Rg,S =
Dg
maxg∈S Dg
− |rg,S|. (5.3.5)
where, Dg is normalized such that it is in the same range as |rg,S|. So, the final score
given by (5.3.5) depends not only on feature g but depends on the discriminant ability
Dg and correlation score rg,S. We take only those genes for which the final absolute
correlation score, R, is greater than 0.5.
5.4 Classification using SVM
The support vector machine (SVM) is one of the methods that has been success-
fully applied to the cancer diagnosis problem in previous studies (Lee and Lee, 2002;
Mukherjee et al.[28]. Let {(x1, y1), (x2, y2), (x3, y3), ...., (xn, yn)} be the training sam-
ples, where yi = +1 or −1 according as xi is in class 1 or class 2. The points
xi, i = 1, 2, ...., n are p-dimensional points. This data set is called the training set.
We are interested whether we can separate these d-dimensional points xi by a (p−1)-
dimensional hyper-plane, just as points in a plane by a straight line on the plane.
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This is a form of linear classifier. Although there are many linear classifiers but there
is just one which maximizes the separation between the points of two classes. Such
a hyper-plane is known as the maximum margin hyper-plane (optimal hyper-plane)
and such a linear classifier is known as a maximum margin classifier.
In two-class classification, the linear SVM fits a model
f(x) = b0 +
p∑
j=1
bjxj
that minimizes
n∑
i=1
(1− yif(xi))+ + λ
2
(||b1||2 + ......+ ||bp||2) (5.4.6)
The classification decision is then made according to sign[f(x)]. The weakness of
the SVM is that it only estimates sign[p(x)− 1
2
], where the probability p(x) = P (C =
1|X = x) is the conditional probability of a point being in class 1 given that X = x.
In multi-class classification, the one-vs-rest scheme is often used: given K classes,
the problem is divided into a series of K one-vs-rest problems, and each one-vs-rest
problem is addressed by a different class-specific SVM classifier (e.g. class 1 vs. not
class 1); then a new sample takes the class of the classifier with the largest real valued
output c = argmaxk=1,2,...,K fk, where fk is the real valued output of the kth SVM
classifier. Recently, Lee and Lee (2002) extends the two-class SVM to the multiclass
case in a more direct way and estimates argmaxkP (C = k|X = x) directly, but it still
lacks the estimates of P (C = k|X = x) themselves.
5.5 Application
Binary Classification
In this section we will apply the logistic regression method for the binary classification
of the Golub data. The genes were selected by using the Behrens-Fisher method as
proposed in chapter 2. The logistic discrimination highly suffered from the high-
dimension of the data, so we could not perform the logistic discrimination using all
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the genes selected by the BF method. Instead, we filtered the highly correlated genes
as in Liu [27]. The number of genes selected was reduced in number from 639 when
not taking the correlation among the genes to 25 after taking the correlation among
the genes into account.
We have used Weighted Vote method, Support Vector Machines and the Multi-
class method of Dudoit for assigning the class labels of the Golub data. In each of
these methods, we used the same 25 genes obtained as above after filtering the highly
correlated genes. The result has been shown in the Table 5.3.
Method Errors
Train Test Total % Error
ALL AML ALL AML
Wt. Vote 0 0 1 1 2 5.89
SVM 0 0 2 1 3 8.82
Multiclass 0 0 0 1 1 2.94
Table 5.3: Classification of Golub Data taking into Correlation among the genes
From the above table we see that, in the case of two class classification, the filter-
ing of highly correlated genes shows the better performance than its non-filtering of
correlated genes counterpart. The above classification result is almost similar to the
method used by [55] in which they have found that 3 samples misclassified using the
22 genes.
Multiclass classification using SVM
This section discusses the application of the support vector machines in classify-
ing the samples from real leukemia data. The data is taken from Yeoh et. al (2002).
There are 12,625 genes and 7 classes. The total number of training samples are 215
and test samples are 112. Hence the data is 12625× 327 matrix. After pre-processing
steps of the training samples as mentioned in Dudoit et al [10], 11,960 genes are re-
maining. We selected those genes in the new test samples which were remaining after
the pre-processing steps. We have used these remaining genes for determining the
marker genes that are helpful for classifying the one kind of sample versus the rest
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samples.
In all the genes selection process, I have used the Behrens-Fisher method to select
the differentially expressed genes between one kind of sample versus the rest samples.
In the multiclass classification, there are two approaches:
• One versus All Method
• One by One Method
The idea of binary classification rule can be extended to multiclass classification.
In the one versus all method, the samples are classified by the classifier in the two
classes. Let there are C classes. We construct C binary classifiers. The kth classifier
is trained to classify the kth class from the remaining classes. If any sample is clas-
sified in two or more than two classes, then the majority of vote is taken and assign
the class of that sample. In the One by One method, we construct the all possible
binary classifiers. as in the One versus All method, if some samples are classified in
more than two classes, the majority of vote is taken and assign the class of that sample.
Quantiles Score(R) > No. of misclassified Samples(train, test) No. of genes
Wt. Vote SVM Dudoit Multiclass
50% -0.1389128 0,2 1,1 0,2 639
55% -0.0628013 0,2 1,2 0,2 639
60% 0.01331021 0,2 0,3 0,2 625
65% 0.089421 1,2 0,3 0,2 526
70% 0.165532 0,2 0,3 0,2 418
75% 0.2416447 0,2 0,3 0,2 300
80% 0.317756 0,2 0,3 0,2 161
85% 0.393867 0,2 0,3 0,2 89
87% 0.425267 0,2 0,3 0,1 47
88% 0.431419 0,2 0,3 0,1 32
89% 0.458178 0,2 0,3 0,1 27
90% 0.469979 0,2 0,3 0,1 25
91% 0.514972 1,2 1,3 2,1 23
95% 0.5460907 2,3 1,3 2,2 16
Table 5.4: Comparison of Classification Performance on Golub Data after taking into cor-
relation between the genes. Different percentage points were used to determine the optimal
cut-point.
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When taking account of correlation between the genes, we select those genes which
have high discriminating power and that have no redundancy information due to
correlation. So, we will determine the score of these genes. From the Table 5.4
we see that when we choose the score above 90%, then the classifiers has the best
performance. So, we take 90% score as the threshold for determining the number of
genes in the correlated data for classification. It has also seen from the Table 5.4
that the larger the value of discrimination score, R, the better the performance. The
discrimination power increases until it reaches some value then begin to decrease. All
the genes selected by the proposed BF method also does not have much discriminating
power, unless we take the correlation of the genes into account. These selected genes
before taking correlation is just adding the noise for the classifiers. The percentage
points are calculated by dividing the difference of maximum and minimum final scores
into equal 100 parts.
When selecting the genes, I selected the genes using the proposed Beherns Fisher
(BF) Statistic. I took one training sample from the rest of the training samples and
selected the genes controlling the FDR at the level 0.05. Then, I took account of
the correlation between the selected genes as in Liu et al. [27]. This procedure was
repeated for each of the 7 classes. Finally, the common genes selected between BCR
vs. rest and E2A vs. rest was used to classify BCR test samples with the E2A test
samples, and so on.
Classes No. of No. of Samples No. of Cost No. of Mis-
genes Train Test SV (γ) classifications
BCR vs. E2A 6 18,9 9,6 5 0.1167 0,0
E2A vs. HYP 12 42,18 22,9 4 0.083 0,1
HYP vs. MLL 2 14,42 6,22 5 0.5 1,2
MLL vs. T.ALL 7 28,14 15,6 5 0.143 0,1
T.ALL vs. TEL.AML 10 28,52 15,27 5 0.1 0,0
TEL.AML vs. Others 9 52,52 27,27 13 0.111 2,3
Table 5.5: Comparison of Classification Performance on ALL-7 Data using the genes Selected
by the BF method and taking into correlation between the genes. The classes were compared
using one versus another.
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Weighted Vote SVM Dudoit
Predicted Class True class True class True class
ALL AML ALL AML ALL AML
ALL 19 1 19 2 20 1
AML 1 13 1 12 0 13
Table 5.6: Confusion Matrices of Test samples of Golub Data by Weighted Vote, SVM and
Dudoit methods
Training Sample Test Sample
Pred. Class True Class True Class
ALL MLL AML ALL MLL AML
ALL 20 3 0 2 1 0
MLL 0 12 2 2 2 0
AML 0 2 18 0 0 8
Table 5.7: Confusion Matrix of MLL data applying the Dudioit Classification method after
taking correlation
5.6 Confusion Matrices
The confusion matrices for the Golub data is shown in the Table 5.6. In the table, only
the confusion matrices of test samples have been shown. The classification methods
made no error in the training samples. Each method used the same set of 25 genes
for the classification. These genes were selected after the taking account of correla-
tion. The classification performance was improved comparing to before correlation,
alt least, in terms of cost. In the previous chapter 3, the number of genes used for
the classification was 639, but here is just 25. genes. This mens that if we take just
these 25 genes, then the classification performance is almost equal to that of taking
639 genes.
The following Table 5.7 shows the confusion matrix for the MLL 3 classes data as
described in Chapter 2.
From the tables of confusion matrices, we see that the classification performance
of the classifiers is greatly increased even with small number of genes. In each of the
methods, the genes used for classification is less than 10. So, in terms of cost, the
methods are suitable for classification.
Now we are going to calculate the assessments of different classifiers. If two clas-
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Training Sample Test Sample
Pred. Class True Class True Class
ALL MLL AML ALL MLL AML
ALL 20 1 0 3 1 0
MLL 0 15 0 1 2 0
AML 0 1 20 0 0 8
Table 5.8: Confusion Matrix of MLL data applying the Weighted Vote Classification method
after taking correlation
Training Sample Test Sample
Pred. Class True Class True Class
ALL MLL AML ALL MLL AML
ALL 19 1 1 3 1 0
MLL 0 12 0 0 1 0
AML 1 4 9 1 1 8
Table 5.9: Confusion Matrix of MLL data applying the SVM Classification method after
taking correlation
sifiers are used to classify the test samples after they were trained on the same
training sets, the number of misclassifications by each methods (called errors) are
calculated and put as in the contingency table. For comparing the performance of
Dudoit multi-class method and Support Vector Machines method on the classification
of Golub test samples, we get the contingency table 5.10. The McNemars statistic,
M = 0.5 < χ2(1), 0.05 = 3.84. So, we conclude that the two methods have same error
rates.
Dudoit Method
SVM 1 2
Method 0 29
Table 5.10: Contingency table for misclassification of Golub Test Data
Similarly the performance of the classifiers on the MLL data can be determined
from the following Contingency Table 5.11. The McNemars statistic M = 0 <
χ2(1), 0.05 = 3.84. So, we conclude that these two methods- Wt. Vote and SVM
Method, have same error rates.
The performance of classifiers are given in Tables 3.8 and Table 3.7 of Chapter 3.
In the chapter 3, we had trained classifiers using leave one out method.
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Wt. Vote
SVM 8 2
Method 1 4
Table 5.11: Contingency table for misclassification of MLL Test Data
5.7 Binary Accuracy Measures
Different measures of accuracy of binary classifiers are obtained from the confusion
matrix of Table 5.2. The various measure of prediction accuracy from the confusion
matrix of binary classifier are given in the Table 5.12:
Measure Calculation
Correct Classification Rate (CCR) (a+ d)/N
Misclassification Rate (b+ c)/N
Sensitivity a/(a+ c)
Specificity d/(b+ d)
False positive Rate b/(b+ d)
False Negative Rate c/(a+ c)
Table 5.12: Confusion matrix derived accuracy measures, N = a+ b+ c+ d
The accuracy measures have been calculated for the Golub data for the classifiers:
Wt. Vote, SVM, Logistic Discrimination and Dudoit Multiclass methods. These are
shown in the following Table 5.13.
Measure Wt. Vote SVM Dudoit Logistic
Correct Classification Rate (CCR) 0.941 0.912 0.971 0.853
Misclassification Rate 0.059 0.089 0.029 0.147
Sensitivity 0.95 0.95 1 0.85
Specificity 0.929 0.857 0.928 0.857
False positive Rate 0.071 0.143 0.072 0.143
False Negative Rate 0.05 0.05 0 0.15
Table 5.13: Accuracy measures for the Wt. Vote, SVM, Logistic Discrimination and Dudoit
Multi-class Classifiers
From the Table 5.13, we can see that the Dudoit multi-class method has the highest
correct classfication rate (CCR) compared to other three classifiers. The sensitivity
and specificity are the probabilities of predicting the same classes of the samples if
they are actually in that class. So, those classifiers whose sensitivity and specificity
alongwith the CCR are higher are the best classifiers. From the table we see that all
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the classifiers perform superiorly if we take the correlation of the genes into account.
5.8 Classification using the genes selected by the Correlated test Statis-
tics
The classification was also done using the genes selected by the correlated test statis-
tics method. In the correlated test statistic method, we have used only those genes
selected by the proposed BF method. We selected 100 genes as in chapter 4. These
genes are used to classify the Golub data. The classification table is shown below:
Method Errors
Train Test Total % Error
ALL AML ALL AML
Wt. Vote 0 0 0 0 0 0
SVM 0 0 0 0 0 0
Multiclass 3 0 0 0 0 8.82
Table 5.14: Classification of Golub Data taking into Correlated test statistics
From the Table 5.14 we see that the 100 genes selected by the correlated test
statistic method classifies the sample better than any other method. Although there is
a training error, there is no test error for the Golub data. So, this set of genes are found
extremely important for classification since it gave the best result for classification
compared to all other previous methods.
5.9 Conclusion
In this chapter we have introduced the effect of correlation on the classification. We
have selected the genes such that the effect of correlation is minimized and these
genes have more discriminating power. The result of this has been studied from the
performance of different classifiers. We have found that after taking the correlation
into account, there is an improvement in discriminating samples. Instead of using all
the genes, only the small number of genes were found useful for improving classification
performance.
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Chapter 6
Future Research
In this dissertation, we have introduced the Behrens-Fisher distribution to select the
differentially expressed genes and used those genes to classify the different types of
cancers. Although we have identified the expressed genes, but there may be some
genes which are not statistically significant but may work in a group. My future work
will be to find the cluster of genes which are functionally similar.
In the microarray data, outliers are also present because of the measurement error
and other sources. The expression levels of such outliers have not been accounted.
Before analyzing such a data, one has to identify and remove such an outliers. Pres-
ence of such an outlier might distort the result. So, I will work to identify the outliers
and remove them in my future work.
Finally, since the dimension reduction is extremely important for correct classifi-
cation of samples using the microarray data, I will work on this aspect as well in my
future research.
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